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INTRODUCTION 
Psychiatrists are frequently confronted with psychoses that are difficult to 
classify. 
Many forms of these atypical psychoses have been described in European 
literature. They often have an acute onset and a tendency towards complete 
remission, albeit with an episodic course. Rich, multiform symptomatology is 
noted sometimes in addition to altered states of consciousness. 
In patients with a grossly impaired consciousness the psychiatrist has also to 
consider whether such a psychosis is due to organic factors or is functional (I). 
Even when morphologically demonstrable organic factors are excluded, the 
possibility of a reaction of the brain to subtle toxic factors disturbing the normal 
physico-chemical equilibrium without causing cellular damage has to be taken 
into account. 
An intermittent production of such toxins in the brain or the liver has been an 
attractive concept for many researchers to understand and account for the 
endogenous functional psychoses (2). 
In this thesis an attempt is made to provide clinical evidence for the endogenous 
synthesis of toxic factors which are causally related to some types of the 
atypical psychoses. The findings have led to a new classification of the group of 
poorly defined and previously unclassifiable psychoses. 
Literature 
1. Jaspers, K. Allgemeine Psychopathologie (1973). Springer Verlag, Berlin, 383. 
2. Baruk, H. Psychoses from digestive origins. In: The Biological Basis of 
Schizophrenia. Eds. Hemmings, G., and Hemmings, W .A., MTP Press Limited, 
Lancaster, 1978, 37-44. 
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CHAPTER I. 
A CASE HISTORY: INVOLVEMENT OF DYSMETHYLATION AS A 
POSSIBLE CAUSE FOR THE PSYCHOSIS 
Two highly controversial problems of clinical psychiatry are discussed in this 
chapter. 
The first problem concerns the old idea that certain forms of insanity, in 
particular the schizophrenic psychoses, are caused by endogenously produced 
toxins (1). 
The second problem, which has been discussed for almost a century, is the 
question whether a separate group of psychoses might exist that, though the 
clinical picture of these psychoses comprises a mixture of affective and alleged 
schizophrenic symptoms, is not a variety of Manic-Depressive Illness or Schizo-
phrenia. 
The case of one particular patient, described below, led us to the idea that a 
psychotic state which lacked the classical symptoms of organic brain dysfunc-
tion, especially impairment of consciousness, could be caused by the endogenous 
formation of a well-known type of psychotoxin. 
The historical roots of this idea go back to the first decades of.this century. As 
early as 1921 the urines of acute schizophrenics were found to form black 
precipitates with silver nitrate. This black reaction of amino substances was not 
found in urines of controls. In the following decades abnormal levels of indole 
compounds were discovered in the urine and serum of chronic schizophrenics (1). 
Transmethylation hypothesis of schizophrenia 
The transmethylation hypothesis, first proposed by Osmond and Smythies in 1952 
(2) was a major advance in research into the aberrant biochemistry of schizo-
phrenia. 
The resemblance between mescaline and noradrenaline was stressed by these 
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authors who suggested that schizophrenia resulted from the faulty methylation 
of excessive catecholamines, released under stress. 
In this they followed Harley-Mason's suggestion that 3,~-dimethoxyphenyl­
ethylamine (DMPEA) was a likely candidate as a psychotogenic substance, for it 
was reported to be highly potent in producing catatonia in animals. Thus, instead 
of normal N- and 0-methylation, abnormal 0-methylation of catecholamines 
would occur in schizophrenia. As a result of their studies, it was realized that 
most of the hallucinogens had an indole nucleus. In order not to abandon the 
original hypothesis, it was assumed that the side chain of mescaline readily fused 
by its aminogroup formed an indole compound. 
The chance observation that somewhat deteriorated adrenaline solutions gave 
unfavourable mental reactions resulted in the notion that this had to be due to a 
derivative of adrenalin, adrenochrome which has also an indole structure. 
Administration of adrenochrome did evoke typical psychedelic experiences (3, 4). 
However, the adrenochrome hypothesis has since been abandoned as adreno-
chrome can not be detected in body fluids of schizophrenics or normals (5, 6), 
and catecholamines present in or added in physiological quantities to plasma are 
found to be stable in plasma from both normal and schizophrenic subjects (7, 8). 
When another class of hallucinogens was detected, namely the methylated 
derivatives of serotonin, N,N-dimethyltryptamine, 5-methoxydimethyltryptamine 
and 5-methoxytryptamine (9, 10, II) the original hypothesis was extended to the 
abnormal N-methylation of indolamines. A hypothesis that found considerable 
substantiation when enzymatic formation of such substances was demonstrated 
(12, 13, 1~, 15). 
Support for a faulty methylation of catecholamines or indolamines was acquired 
through the experiments of Pollin et al., loading chronic schizophrenic patients 
with the methyldonor substance methionine combined with a MAO-inhibitor (16). 
Exacerbations of psychotic symptoms or a superimposed toxic psychotic state 
were noted in many chronic schizophrenic patients (approx. 58%) by independent 
groups of investigators (17, 18, 19). 
Large doses of methionine (5-~0 gram/70 kg/day) were administered for periods 
of one week up till two months. Even when no MAO-inhibitor was used almost 
half of the patients had psychotic symptoms (20, 21), the return of specific 
hallucinations and delusions that some patients had shown years before has been 
reported (2 1 ). 
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CASE HISTORY 
The first patient, 24-year-old, unmarried, female, was admitted to the uni-
versity hospital after she had attempted suicide by jumping out of a window at 
the command of her auditory hallucinations. As a result she had broken a leg, 
which made an operation under general anaesthesia necessary. Afterwards she 
seemed confused: psychiatric examination showed that she was still suffering 
from auditive (imperative) and also from multi-coloured visual hallucinations (in 
the form of 'ghosts'). She stated that time was going very fast, was 'bombing her', 
or had come to a complete standstill. Movements were so fast that she was 
unable to follow them. The white hospital room seemed larger and full of colours 
and in combination with the 'ghosts' it resembled a temple. Faces of doctors and 
nurses were impossible to recognize as a result of deformation and colouring. 
She was often extremely perplexed and complained about strange bodily feelings 
and sometimes haptic hallucinations. Anxiety was overwhelming, though she 
remained passive most of the time. 
Occasionally this akinetic state was disrupted with the risk of violent suicide. 
Voices ordered her to burn or otherwise mutilate herself. Wide pupils, perspira-
tion, tachycardia etc., even when she was not anxious, indicated a strong 
orthosympathic involvement. 
This state, resembling that described for experimental psychoses induced by 
hallucinogenic chemicals like LSD, mescaline etc. was not affected by neuro-
leptics. 
During the two months following admission, neurological symptoms became 
prominent: signs of neuropathy, diplopia and progressive paresis. Vitamin B 12 
was given in large doses: the neurological symptoms disappeared within a few 
days. The hallucinations gradually disappeared, but accidentally a DolviranR 
tablet was administered, containing a.o. barbiturates. Within an hour the hallu-
cinosis described before, fully re-appeared. An acute intermittent porphyria 
(AlP) was strongly suspected then. 
Cataleptic states, lasting several hours and sometimes preceded by abdominal 
cramps completed the picture. Once an epileptic fit occurred. Fatal outcome 
was feared when Cheyne-Stokes breathing patterns were observed. 
On the assumption that our patient was suffering from AlP a diet, rich in 
carbohydrates, free of fat and with minimal protein (especially with a low 
content of the aminoacids methionine, serine, glycine and tryptophan) was given, 
when necessary, by force. To the surprise of everyone the patient recovered 
completely within four days and no residual symptoms could be demonstrated. 
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Short relapses occurred after the (forbidden) eating of herrings and later of 
French fried patatoes with mayonaise, and often in the premenstrual period. 
For a period of four months our patient remained free of psychotic symptoms. 
But during a premenstrual period she suffered from a dysforlc mood and 
thereupon refused to take any food. During the following weeks a totally 
different clinical picture developed. She showed a strong tendency to sing all day 
long, to make repetitive compulsive movements; she walked excitedly along the 
corridors and did not sleep or eat. There were no hallucinations but patient 
showed clear paranoid delusions. Instead of the akinetic-hallucinatory mescaline 
or LSD-like syndrome a hyperkinetic-paranoid amphetamine-like syndrome had 
developed and in concordance with the latter, neuroleptics were able to suppress 
the symptoms. 
Adding extra tryptophan (1.5 gram/day) to the diet, made the akinetic-hallu-
cinatory syndrome re-appear. After high calorie feeding for a few days she 
improved. 
Further premenstrual induction of (pr2sychotic 
prevented by regular medrogeston (Colpro~ intake. 
Previous psychotic episodes 
symptoms was succesfully 
From descriptions of previous clinical admissions the great diversity of psychotic 
states was striking. Not only regarding the different pictures reported, but also 
with regard to the length of the psychotic episodes, varying from days to months, 
although complete recovery after every episode was evident. 
Extreme_ states of depersonalization, especially of the somatopsychic type, 
during which patient said to feel like a robot, walking on fluff etc. were 
reported. These feelings of depersonalization were often followed by auditory 
hallucinations such as the singing of birds and voices commanding her to commit 
suicide. 
Also short perceptual distortions of faces and hallucinations of coloured stains 
and circles were reported. Often her experiences were extremely terrifying -
auditory and visual hallucinations of yelping wolves, roaring lions and deformed 
human faces and bodies. 
Hypomanic periods, especially during evenings and nights, besides prolonged 
depressive episodes with distinct feelings of insufficiency and worthlessness were 
frequently reported but often these symptoms were dominated by paranoid 
ideation. 
Diagnoses of temporal lobe epilepsy and manic-depressive illness were consid-
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ered. Electro-encephalography did not substantiate the idea of temporal lobe 
epilepsy. Carbamazepine treatment had no effect and moreover seemed to 
worsen the psychosis. Treatment with lithium did not prove to be effective. 
Neuroleptics had some beneficial effects when sedation occurred. Recovery 
seemed to occur spontaneously and behaviour between psychotic episodes is 
described as 'impressively' normal. 
Laboratory findings 
Renal and liver function tests, red and white blood cell count, and hematogram 
were normal. Vitamin deficiences of folic acid, B12 (estimated before the 
vitamin B 12 administration), B 1 and B 6 could not be demonstrated. 
Also urinary corticosteroid excretion and thyroid function were normal. 
Concentrations of uro- and coproporphyrines in urine and copra-and proto-
porphyrines in faeces were repeatedly normal. After the Dolviran® tablet had 
accidentally been administered porphobilinogen (PBG) was qualitatively present 
in urine. Uroporphyrin !-synthetase concentration in red blood cells was also 
normal. 
During psychotic states the glycine concentration in urine was increased. 
Electro-encephalographic recordings, made during psychoses, did not show dis-
tinct anomalies. 
PSYCHOTIC ILLNESS DUE TO ACUTE INTERMITTENT PORPHYRIA ? 
In the present case history three aspects deserve attention: firstly, the frequent 
psychotic episodes since the menarche showed a great diversity of symptoms, 
whereas recovery was always complete. 
Secondly, the clinical picture as observed after operation, resembled the 
hallucinogenic drug-induced state of LSD and mescaline. A later episode bears 
all the characteristics of an amphetamine-like psychosis. 
Thirdly, the clinical course, the induction of the psychoses and concomitant 
somatic manifestations and the beneficial effect of the glucose diet led us to 
consider the diagnosis of acute intermittent porphyria as the basic metabolic 
disturbance. 
However, the assumption that the underlying basis of the psychoses of our 
patient was porphyria, could not be confirmed biochemically. 
Shortly after the successful treatment of the first patient, another girl was 
admitted into the university hospital, who was also suffering from a psychosis 
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characterized by multiple disturbances of sensory perception and catatonic 
features, acutely evoked after administration of barbiturates and sulfaprepara-
tions. Abnormal porphyrin excretion was found in urine. Together with the 
observations mentioned above, this aroused our interest in the psychiatric 
aspects and the biochemical basis of porphyria. 
Psychiatric aspects of acute intermittent porphyria 
AIP with its high incidence of mental symptoms is an attractive model for 
studying the molecular bases of psychiatric diseases (22). 
Psychiatric symptoms often accompany attacks of the hepatic porphyrias, 
especially acute intermittent porphyria, porphyria variegata and hereditary 
coproporphyria. 
The incidence of psychiatric symptoms assumed to be related to the porphyric 
disease is 15-80% (23, 24, 25). Psychiatric symptoms can precede the neuro-
logical and abdominal manifestations of porphyric attacks, or may be so 
overwhelming that little attention is paid to them (26, 27). In this respect our 
first patient was no exception. 
These psychopathological symptoms are not found in porphyria cutanea tarda 
(symptomatica) (PCT), or, when present, they are related to the etiology of PCT, 
such as alcohol addiction, intoxication by herbicides, pellagra, etc., and are not 
the consequence of the increased porphyrin biosynthesis (23). 
Accqrding to the literature five types of psychiatric syndromes can be distin-
guished during porphyric attacks. 
a) anxiety and emotional lability (28, 29). 
b) so-called hysterical behaviour such as 'loud shrieking and a curious position in 
bed, rarely noted in other somatic diseases' (30). This behaviour seems to be 
induced by colicky pains, which in its turn is often misdiagnosed as a 
symptom of hysterical conversion, in particular when curious pareses are 
observed (31, 32). 
c) confused or delirious states, clearly pointing to an organic brain syndrome 
(23, 21f, 28, 29, 30, 31). When hallucinations are present they are mostly of a 
visual nature (33). 
d) depressed, dysphoric or apathic states of mind, in some cases not subsiding 
immediately after an acute attack (21f, 32). 
e) 'schizophrenic' states (the term is loosely used for all sorts of psychoses with 
unimpaired consciousness) (34, 35). 
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It remains obscure, however, whether these schizophrenias and porphyric dis-
eases are pathogenetically related, or whether both clinical conditions occur in a 
patient by chance. Some authors suggest a possible causal relationship, but this is 
refuted by others (29, 36). 
An exception in this respect is the report of a prolonged auditory hallucinosis 
which was found to be related to AlP (37). 
Thus, it is evident that with regard to the types of mental disturbances 
mentioned in the literature, our first patients, who were supposed to suffer from 
porphyria, are great exceptions. Their characteristically psychotic states without 
impaired consciousness, not resembling the classical organic brain syndromes 
have not been reported previously. 
Biochemical aspects of porphyria 
Before us, many authors have tried to understand psychiatric symptomatology in 
porphyric disease from what is known of the deranged biochemistry of the latter. 
Porphyrins are synthesized from succinate and glycine via the enzyme amino-
laevulinic acid synthetase. ALA synthetase is the rate-limiting step in the 
porphyrin biosynthesis and this enzyme can be activated by steroids or barbitu-
rates and can be inhibited by glucose and by the end product heme (23). 
A def_icient enzyme in the porphyrin pathway (uroporphyrin !-synthetase in the 
case of AlP) will cause a decreased production of heme. This leads to a 
decreased feedback repression and activation of ALA synthetase thus increasing 
the formation of precursors of the porphyrins (ALA and PBG). During induction 
of ALA synthetase more succinate and more glycine will be needed. 
Similar to the hypothesis to be forwarded in this thesis is the idea of De Matteis 
(38). De Matte is reasoned that the preferential metabolism of glycine through 
the succinate-aminolevulinic acid cycle rather than the acetate-aminoaceton 
cycle arises from decreased availability of acetyl CoA. This will also result in a 
decreased synthesis of acetylcholine in nervous tissue. 
When compared to pharmacologically induced anti-cholinergic states, such a 
hypothesis can explain the occurrence of confused and delirious states. It is 
partly contradicted, however, by the fact that normal quantities of aminoaceton 
are excreted in AlP (39). 
Most theories focus on the products of the aberrant porphyrin synthesis to 
explain the observed neuro-psychiatric disturbances in porphyric diseases. 
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During an attack of AlP aminolevulinic acid and porphobilinogen are synthesized 
and excreted in abundance due to the failing end product (heme) inhibition of the 
enzyme ALA synthase. These products may be responsible for psychiatric 
symptoms, although ALA and PBG hardly penetrate into the central nervous 
system (CNS) (approximately ~% of the blood concentration is found in liquor). 
But when administer.ed intraventricular in animals it does give behavioural 
changes (~0). 
In addition, i~ has been demonstrated that both ALA and PBG have a depressant 
$ffect, like gamma aminobutyric acid (GABA) on the spinal cord, ALA more so 
than PBG. The ALA concentration needed for this effect is equal to the blood 
concentration attained during an acute attack of AlP ('+1). 
More investigators have pointed out the effects of ALA on the GABA-ergic 
neurons (~2, ~3, ~~), and recently Brennan and Cantrill (~5) showed that ALA can 
compete with GABA for presynaptic receptors in the mammalian CNS. It reduces 
potassium depolarization-induced release of GABA in a concentration 
(1.6-2 x 10-5 M) that can be reached in cerebrospinal fluid during an acute 
attack of AlP. This effect is of special interest, as it may offer an explanation 
for the occurrence of hyperexitability and seizures observed during acute attacks 
of porphyria. It is unlikely that the characteristic psychoses presented here can 
be understood from such a disturbance of the GABA-ergic system. 
The organic brain syndromes, confused and delirious states, observed during an 
attack of AlP, can also be caused by hyponatriaemia, which is often the result of 
excessive vomiting, renal loss of sodium or inappropriate secretion of anti-
diuretic hormone (~6). 
Mauve factor 
Another possibility that relates porphyria and its concomitant psychoses was the 
finding of an Ehrlich-positive substance, thought to be related to the pyrroles. 
This substance was reported to be found in the urines of schizophrenic patients 
(mainly paranoid and undifferentiated types; 47). 
This mauve factor, named after its colour in the chromatogram, led Hoffer and 
Osmond, a little prematurely, to introduce a new entity of psychiatric disease, 
Mal varia (~8). 
Patients who excreted the mauve factor, thus suffering from Malvaria, were 
reported to be severely psychotic, with perceptual changes, thinking disorders, 
incongruencies in affect and behaviour. The mauve factor has been demonstrated 
by several groups of investigators, and, although most frequent (about 50%) 
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found in urine of schizophrenic patients, it was also present in urine of healthy 
persons, cancer patients, epileptic~, alcoholics, neurotics and otherwise mentally 
disabled patients (49, 50, 51). 
Finally, the mauve factor in urine of schizophrenics was identified with 
phenothiazine metabolites, a fact that might be due to a different extraction 
method (53). 
Nevertheless, the Irvine and the Sohler group succeeded in identifying the mauve 
spot as being 2,4-dimethyl-3-ethyl pyrrole (kryptopyrrol) which interestingly 
resembles the indol tryptamine and related hallucinogenic substances (53, 54). 
Gendler et al. failed, however, to detect kryptopyrrole or its isomer haemo-
pyrrole in schizophrenics and controls (which includes AlP patients) (55). 
With refined methods the 'natural' kryptopyrrole was proven to be identical with 
the oxidized lactam form of heamopyrrole (2,3-dimethyl-4-ethylpyrrole): viz. 
hydroxyheamopyrrollin-2-one (OH-HPL). 
This metabolite is supposed to be easily formed from PBG and was found in the 
urines of patients with AlP and of psychiatric patients (56). This OH-HPL was 
found to be related to the urinary ALA concentration in AlP and was also 
increased in 4 out of 7 schizophrenic and 4 out of 6 patients suffering from 
orgah~c brain syndromes. In these psychiatric patients no relation with ALA (or 
PBG) concentration has been found (57). 
Gorchein reports that OH-HPL could not only be detected in the urines of 
schizophrenics, but also in those of normals of otherwise general medical 
subjects. The excretion of these monopyrroles in AlP did not correlate with ALA 
of PBG concentration or the clinical state of the patient (58). 
In conclusion, the relation of the monopyrroles to psychoses and porphyria 
remains conflicting and obscure at this moment. Nor do the other findings and 
theories regarding the relationship of porphyria and psychoses offer an explana-
tion as to how porphyric disease and hallucinogenic-like psychotic states can be 
related. 
EXCESSIVE PYRROL SYNTHESIS, ONE-CARBON METABOLISM AND 
BIOGENESIS OF HALLUCINOGENIC SUBSTANCES: A HYPOTHESIS 
The assumption of the theory presented here is that in the patients studied, 
hallucinogenic substances were endogenously synthesized due to aberrant pyrrol 
synthesis. 
The idea of endogenous formation of hallucinogenic substances has recently been 
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reviewed by Bruinvels (59). From the data presented in the literature it was 
concluded that psychotomimetic substances could be synthesized endogenously 
from the normal monoamines under conditions in which methylene and/or methyl 
tetrahydrofolic acid (THF)concentrations are increased to such an extent, that 
the normal flow of one-carbon units via the vitamin B 12-dependent enzyme 
homocysteine methyltransferase (yielding methionine) becomes impaired. 
One-carbon groups are thus trapped. 
Under such circumstances abnormal methylation of monoamines may become 
possible. 
Many of these products are identical with well-known potent hallucinogens, a 
fact that has led to much research and speculations about this theory of 
abnormal methylation next to other theories in the area of schizophrenia (60, 61, 
62, 63). 
Later it was shown that it is not methylation but cyclization of monoamines by a 
non-enzymatic reaction of formaldehyde derived from methylene-THF that is 
probably responsible for the formation of psychotogenic substances (For a review 
see: 64). 
This induced the hypothesis that 'hyperformaldehydism' may be the biochemical 
etiology of schizophrenia (65). 
On realizing that an excess synthesis of methylenated folates could be the key 
problem, we sought for a biochemical explanation of the case presented. 
As pointed out by Bruinvels (59), the ultimate source of one-carbon neogenesis is 
the hydroxymethyl group of serine. 
This aminoacid is converted into glycine by the enzyme serine hydroxymethyl-
transferase (SHMT) in which tetrahydrofolic acid, as a co-factor, accepts the 
one-carbon moiety as methylene (CH2= THF). The enzyme requires pyridoxal 
5'-phosphate for activity (66, 67, 68). Subsequently, assuming that the patient 
described was suffering from AlP, we realized that great amounts of glycine had 
to be formed from serine in order to meet the increased demands for glycine 
during increased pyrrol synthesis in porphyric attacks. Glycine and succinyl-CoA 
are the precursors in pyrrol synthesis. Thus, during excess pyrrol synthesis 
abundant formation of CH2=THF will occur, since exogenous sources of glycine 
are even in normal circumstancs insufficient to meet the daily needs (67). 
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METHYL(ENE) TRAPPING AND PSYCHOSES DUE TO OTHER METABOLIC 
DISEASES 
Previously, the idea of trapping of one-carbon units and synthesis of hallucino-
genics was studied or at least mentioned as a possible cause of psychotic states 
in relation to well-known disturbances in metabolism and transfer of active 
one-carbon groups. Thus, it is worthwhile to look into these metabolic disorders 
and study possible links with the present case. The hampered one-carbon transfer 
may be caused by vitamin B12 deficiency or genetic of functional deficiencies of 
the enzymes involved in the transport, in particular CH2= THF reductase, 
CH3- THF homocysteine methyltransferase, methionine adenosyl transferase, and 
cystathionine- beta-synthetase. 
A rise in plasma folate (which is mainly CH3 -THF) is observed in s 12 deficient 
animals, while the intracellular fraction of polyglutamate folates decreases and 
the pool sizes of monoglutamate remains constant. 
The ratio of methylated polyglutamate products versus non-methylated products 
is increased, while the amount of CH3 -THF is constant (69). Smith et al. also 
showed that with vitamin B 12 deficiency the folate content of liver decreases 
including the methylated fraction, and pointed to the fact that plasma folate 
content is less than 1% of that in liver (70). 
In agreement with the latter reports are findings demonstrating that folate 
metabolism fails (71) and the oxidation of histidine, formate, sarcosine, serine 
and glycine is decreased (72). 
It is concluded that in a vitamin B 12 deficiency the uptake and possibly the 
retention of folates is afflicted, thus interfering with the simple idea of methyl 
trapping. 
In agreement with these animals data, the clinical literature is also disappointing 
is this respect: the type of psychosis that may be expected as the result of 
methyl trapping, viz. a hallucinogenic drug - like psychosis has not been 
unequivocally reported. 
Nevertheless, mental symptoms ascribed to vitamin B 12 deficiency are esti-
mated to be present in 4.-16% of patients suffering from such a deficiency (73). 
From the introductjon, during the fifties, of routine serum vitamin B 12 assays in 
clinical practice (74.), many reports have been published that pointed to the 
emergence of mental symptoms a long time (up till years) before nnaemic or 
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neurological symptoms were observed; or mental symptoms that had b~en 
minimal and hence (had) escaped attention (7 5). 
The reported cases of (pre)'megaloblastic madness' (76) vary widely in respect to 
their symptomatology: from neurasthenic complaints (especialJy fatigue) to 
apathy, from confusional to delirious states, from memory impairment to gross 
dementia, from regressive behaviour to stupurous states with incontinence etc. 
are described. 
However, severe retarded depressions with a tendency to paranoid ideations or 
delusions and occasionally a (hypo)manic state are also mentioned (73 - 80). 
In many cases favourable outcome of B 12 therapy is stressed, which also 
occurred in the case of a 35 year-old male patient who, 9 years after gastrec-
tomy, had developed a serious organic psychosis. Treatment with B12 injections, 
despite normal serum B 12 concentration, resulted in a prompt and dramatic 
complete amelioration (81). 
(This patient and the patient presented here both demonstrate the necessity of 
discriminative assays for methylated and non-methylated B12, since oversatura-
tion of the B12 pool with methylgroups will result in reduced availability and 
functional deficiency of the non-methylated B12 fraction, while nowadays 
estimations of serum B12 comprises methylated as well as non-methylated B12). 
Surveys of general psychiatric populations, including patients with functional 
psychoses, often show high incidences, up till 10%, of low serum B12 levels with 
or- without low folate concentrations. Pernicious anaemia has only incidentally 
been found as the cause of the deficient state. 
Poor feeding habits and deficient, vegetarian diets, in (arteria sclerotic) de-
mented patients in particular are held responsible (82, 83, 84). 
It appears that there is no causal relationship of the deficient B 12 state with the 
functional psychoses, though precipitation of affective i11ness remains a theoret-
ical possibility. 
A causal relation between B12 deficiency and depression (and mania) is further 
refuted by a prospective study of Shulman (85). Significantly more depressions 
were found to be correlated with vitamin B12 deficiency. 
However, the causal relation is unlikely in view of ,the high incidence of 
depressions among relatives and previous episodes of depressions in the index 
patients. Moreover, relapses of depression during vitamin B12 therapy were 
observed. 
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A careful study of Shorvon (7~) showed that in isolated vitamin B 12 deficiency 
states with concomitant megaloblastic bone marrow 20% of the 50 patients 
suffered from (depressive) affective symptoms and 26% had organic features. In 
contrast, 56% of the 34- patients with a solitary folate deficiency, had affective 
disturbances and 27% organic complications. Thus, in this study vitamin B12 
deficiency was less frequently associated with affective disturbances than folate 
deficiencies. 
Apparently functional florid psychotic states are not caused by vitamin B12 
deficiencies. 
The mention of a 'schizo-affective reaction' related to a low normal B12 
concentration (155 pg/ml) (86) cannot be considered to be proof of the contrary. 
Phenytoin and psychoses 
Another clinical situation that might disturb methyl transfer is during anti-
convulsive treatment of epilepsy. Many anticonvulsants have been implicated in 
folate deficiency eventually resulting in megaloblastic anaemia. Evidence has 
been presented that phenytoin interferes with the conversion of folic add to 
CH3- THF outside the CNS (87, 88) and may therefore be of special interest. 
This fact explains the frequently reported low folate levels during phenytoin 
treatment, since methylated THF makes up the largest pool of plasma folates 
and in daily practice this fraction is measured by a microbiological assay (L. 
casei). CSF folate concentration will also be afflicted since CH3- THF is the only 
folate derivative that is actively transported by the blood-brain-barrier into 
cerebrospinal fluid (CSF) up to three times the plasma concentration (89, 90, 91). 
Diphenylhydantoin lowers CSF folate most (92). 
In the study of Mattson et al. (87) a rise in CSF folates in drug induced folate 
deficient patients is observed after 'Leucovorin1 (= 5-formylTHF), but not after 
folic add therapy. 
In addition, Krause et al. (88) showed that serum and CSF concentration of 
unreduced folates, as measured bY a special competitive protein binding assay, 
were similar in hydantion treated epileptics and controls. 
It may be concluded that the transfer of active C fragments in these patients is 
unimpaired. However, the reduction of folic acid to THF is decreased and the 
capacity to bind one carbon units reduced, leading to a paucity of methylating 
processes in the body. 
In the light of these findings the widely cited report of Reynolds of schizo-
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phrenia-like psychoses during anticonvulsive treatment is of considerable 
interest (93). In four patients, all suffering from temporal lobe epilepsy, the 
development of unmistakably florid schizophreniform psychoses (without dys-
perceptions) was observed after these patients had been treated with a combina-
tion of phenobarbitone and phenytoin most of the time. Recovery from psychosis 
resulted after folic acid and vitamin B 12 administration. In one patient this was 
the only treatment. Next to a low folate level, a rather low B 12 serum 
concentration ( 180 pg/ml) was also found in 3 patients during anticonvulsive 
therapy. It is presumed that the latter disturbance is secondary to the antlfolate 
action of the anti-epileptic drugs (94). 
Here also, the exact quantitative relation of methylated versus non-methylated 
vitamins will considerable add to the understanding of the reported phenomena. 
Reynolds relates his findings to the transmethylation hypothesis of schizophrenia 
(93). However, in the light of present limited knowledge of phenytoin treatment 
and folate metabolism this seems hardly tenable. Following parallel lines of 
reasoning Levi and Waxman (95) postulated that 'schizophrenia' is not provoked 
by excessive and faulty methylation of monoamines, but is instead due to a 
decreased methylation capacity of these patients. A deficiency or functional 
limitation of the enzyme methionine adenosyl-transferase or its co-factors is 
suggested as a possible cause of schizophrenia. 
Decreased activity of S-adenosylmethionine (SAM) dependent methylation, 
however, could not be demonstrated in brains of schizophrenics at autopsy (96), 
and in addition, the activity of methionine adenosyl-transferase in erythrocytes 
has also been found to be normal in schizophrenic patients (97). In contrast, an 
uncontrolled (for diet, environment and therapy) study of Carl et al. (98) showed 
a significant lower activity of serine hydroxymethyl transferase (SHMT) and 
methionine adenosyl transferase in blood cells of schizophrenics compared to 
normals. 
Folate deficiencies and psychosis 
As was to be expected a folate deficiency alone has not been demonstrated to be 
causally related to florid psychotic states. Depressions, fatigue states, organic 
brain syndromes, and neurological symptoms are described in folate deficiencies 
(99, 100, 101). A folate deficiency may affect neurotransmitter metabolism, 
since the pteridines and possibly the pteridine part of the folate molecule are 
important as a co-factor for tyrosine, phenylalanine, and tryptophan hydroxylase 
activity (102), which may explain the depressive symptoms. 
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Methylene reductase deficiency 
A genetic deficiency of the enzyme methylene reductase has been demonstrated 
in children with severe mental retardation and a wide spectrum of neurological 
findings associated with low folate levels, homocystinuria and moderate homo-
cystinaemia, normal of low plasma methionine levels and without abnormal 
hematological findings (103, 104, 105). 
Freeman et al. (106) reported a mildly retarded adolescent girl lacking the 
classical clinical manifestations of homocystinuria but having concentration 
difficulties after the menarche. Her IQ was 60. After an episode with severe 
abdominal pains at the age of 14, she lost contact with her surroundings, 
perseverating and giggling inappropriately. Her verbal IQ was 46, further 
psychological testing was 1indicative of a schizophrenic reaction1• Despite 
continued neuroleptic treatment a psychotic episode emerged with visual and 
auditory hallucinations, nightly terrors, and feelings of being persecuted. The 
episode was further characterized by drowsiness, falling asleep, muteness, and 
incoherent mumbling. There was a questionable seizure, she was incontinent and 
had to be fed. 
Nitrofurantoin medication for a urinary tract infection evoked a rapidly progres-
sive peripheral neuropathy. Folic acid (20 mg/day), administered for 14 days, 
resulted in improvement of the psychotic state and intellectual function. In later 
psychotic periods, the authors mention Bablnksi responses, superimposed on the 
neuropathy, a slow diffusion in the electro-encephalogram, disorientation, and 
inability to recall name and birth date. Recovery from these episodes occurred 
after folic add administration. 
One full sister with an IQ of 62 performed well and showed no psychotic 
symptoms. Neither did she show anomalies of the lens, osteoporosis or thrombo-
embolic phenomena which are present in cases of homocystinuria due to a 
cystathionine beta-synthetase deficiency. In both sisters a reduced activity of 
the 5,10-methylene tetrahydrofolate reductase activity was demonstrated. 
The psychoses, on the strength of psychological tests (Bender-G~stal ~ and 
Rorschach) and the opinions of several psychiatric consultants, were labelled as 
(catatonic) schizophrenia, although the authors in their discussion and by putting 
the word 1schizophrenia1 in the title in quotation markts, apparently leave room 
for another diagnostic view. 
The report of this case history and biochemical findings led to further specula-
tions on and research for a decreased reductase enzyme activity in schizophrenic 
psychosis. However, there is no solid evidence that the enzyme is deficient in 
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schizophrenia (107). 
Apart from biochemical studies and speculations there is little reason to 
characterize the psychotic illness of Freeman's patient as schizophrenic. 
When the IQ has dropped to 46, Bender-Gestalt and Rorschach tests cannot be 
used to substantiate the diagnosis schizophrenia. The drowsiness, the incoherent 
mumbling, the muteness, the incontinence, the disorientation reported later on, 
even when possible seizures are not taken into account, the electro-encephalo-
graphic and other neurologic complications, favour the diagnosis of an organic 
mental syndrome characterized by florid symptomatology. The title of Freeman's 
article is rather misleading and may be illustrative of the vague way the term 
'schizophrenia' can be used in America. 
Methyl transferase deliciency 
A case of homocystlnurla and psychosis due to a deficiency of the CH3- THF 
homocysteine methyl transferase has been reported (108). A 14 year old boy 
suffered from an 'acute psychosis'. He was also moderately mentally retarded 
(IQ 50 WIS for children) and showed some neurological disturbances. Spontaneous 
recovery from the psychosis was observed. Very young children have been 
reported to be more seriously mentally, somatically and biochemically disturbed 
(103, 109). 
The inability to metabolize vitamin B 12 adequately has also been demonstrated 
in severely ill new-born infants (110, 111, 112). These studies do not provide 
further insight into the pathogenesis of the psychosis in our patient. 
Cystathionine beta-synthetase deficiency 
A defiCiency of this enzyme is the most frequent cause of homocystinuria (109). 
The presence of psychosis or schizophrenia in families with homocystlnurla has 
been reported. In one patient with homocystinuria possible schizophrenic symp-
toms were present and it was hypothesized that the abundance of methyl groups 
in the form of methionine in this disorder, caused the psychotic illness, a view 
that is concordant with the idea behind the methionine loading tests (113). 
The psychoses subsequently reported, however, are clearly variable organic brain 
syndromes (I14-117), and the 'schizophrenia' of the relatives are probably not 
related to the homocystinuria, being the chance occurrence of both conditions in 
one family (118, 109). 
Homocystinuria has not been found in retrospective analysis of patients with 
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schizophrenic psychoses (ll8). 
Thus, the clinical pictures presented in the literature do not support unequi vo-
cally the idea of methyl(ene) trapping causing LSD or mescaline-like psychoses 
by the known enzyme and/or co-factor deficiences in the methyl transfer 
pathway. 
Conclusion 
In addition to the knowledge that clinical practice gives poor substantiation to 
the idea of methyl trapping and concomitant characteristic psychiatric distur-
bances, it is equally important to realize that it is a matter of doubt whether the 
enzyme deficiencies mentioned above indeed cause methyl(ene) trapping to such 
extent that abnormal one-carbon transfer will occur. 
The normally operative regulatory mechanisms of the methyl metabolism would 
tend to prevent such a metabolic aberration. 
Though these regulations are not yet completely understood or investigated there 
is ample evidence that the different enzymes involved in one-carbon transfer can 
be inhibited by feedback mechanisms and thus prevent excessive accumulation. 
Some_ of these mechanisms have been elucidated in mammalian tissues (119-122) 
and are briefly discussed here: 
Serine hydroxymethyl transferase (SHMT) is inhibited by one of the derivatives 
of CH2=THF, namely 5-formyl THF. 
CH 2=THF itself and also its derivatives 5,10-methenyl THF, 10-formyl THF and 
5-formyl THF inhibit the reduction of dihydrofolate to THF, resulting in a slow 
reduction of stored THF (most of it being the polyglutamate form of CH3-THF). 
CH2= THF is normally irreversibly reduced to CH 3-THF and this latter product 
strongly inhibits SHMT. 
_ CHO cyclohydrolas'l _ CH dehydrogenase = CH reductase CH 
formyl methenyl methyleni methyf 
The end product of methyl biogenesis S-adenosyl methionine (SAM) inhibits in 
turn the methylene-reductase, while its demethylated product S-adenosyl homo-
cysteine stimulates the reductase. 
Such a cascade of inhibitory mechanisms enables an accurate tuning of one-
,carbon metabolism in many circumstances; trapping at one place will cause 
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inhibition of preceding metabolic conversion and transfer of one-carbon groups. 
\!loreover, the serine - glycine conversion by SHMT is completely reversible, 
glycine can react with CH2= THF to reform serine (67). Although the equilibrium 
is slightly in favour of glycine synthesis, abundant production of glycine and 
CH2= THF is not likely to occur under normal circumstances (see also serine -
glycine metabolism). 
Therefor we can agree with Tisman et al. that 1the methylfolate-trap hypothesis 
should be put to rest, since data from many laboratories cannot be forced to fit 
such a hypothesis' (123). 
Though the comment of Tis man et al. applies to vitamine B 12 deficiency alone, 
we would like to extend it to any disturbing factor along the one-carbon pathway 
from serine to SAM. 
Only conditions under which the normal inhibitory regulatory actions of the 
methyl biogenesis can be circumvented, will result in an increased synthesis and 
guantitively significant trapping of one-carbon moieties. 
Increased serine to glycine conversion during enhanced pyrrol synthesis may be 
such an event in which the body as a side-effect of its demand for glycine is 
forced to produce and accept more one-carbon units than are needed for its 
methylation processes. Of course, other metabolic situations may also cause such 
an unwanted accumulation of active one-carbon fragments. 
SERINE - GLYCINE MET ABOLJSM 
The daily rate of glycine synthesis is approximately 1 gram/kg body wt, the 
endogenous synthesis of glycine is 10-50 times the normal dietary supply. 
Collagen contains 30% glycine, while 60% of non-collagen protein is made up of 
glycine (67). Most glycine is needed for creatine syntheses and is made almost 
exclusively via the hydroxy-pyruvate -serine pathway (67, 12,). 
The other important function of serine-glycine metabolism is the biogenesis of 
one-carbon units. The end product, 5-adenosyl-methionine (SAM), is the pre-
dominant methyl donor in almost all methylation processes and is regarded also 
to be the most important substance in the regulation of the de novo biogenesis of 
one-carbon groups by its feedback inhibition of methylene reductase, enabling a 
rapid regulation of methyl biogenesis (see below). 
The quantitatively most important acceptor of methyl groups (via SAM) is the 
creatine synthesis. In normal, non-fasting conditions some methyl neogenesis is 
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needed, but most methyl groups are derived from the methyl donors choline and 
methionine by food intake (124). 
According to Mudd and Poole (124.), homocysteine recycling doubles under 
conditions of limited protein intake. Thus, during limited protein intake or 
starvation, the body is completely dependent on the serine-glycine conversion for 
its creatine and methyl synthesis. 
Arnstein and Neuberger (66) also found that serine is the methyl donor in these 
circumstances. Glycine itself was found to be insufficient. 
It is easily understood that the activity of the glycine cleavage enzyme 
- breaking down glycine to NH 3 and C02 and yielding also active one-carbon 
groups in the form of CH2= THF - is very low under normal conditions in 
mammalian species (125), since glycine is an important aminoacid that is utilized 
in many ways, e.g. in addition to the synthesis of creatine, synthesis of purines, 
pyrrols, and the conjugation of bile acids etc. 
Glycine catabolism through the succinate-glycine or amino-aceton cycle is 
quantitatively unimportant (125). 
The activity of the enzyme serine dehydratase in the human metabolism, in 
contrast with that of the rat, remains obscure, but it may play some role in 
gluconeogenesis during prolonged starvation (125), when body proteins (up to 
100 gr/day) are broken down in order to supply the glucose dependent energy 
needs of the brain (126). 
In normal, non-fasting conditions, the serine-glycine equilibrium is in favour of 
glycine synthesis (67). 
When administered, glycine is also rapidly converted to serine. In addition, there 
is evidence that glycine methylation serves for metabolic removal of 'excess' 
labile methyl groups (127). 
The complex and poorly understood serine-glycine metabolism Js further com-
plicated by cellular compartimentization (67, 121, 125, 128-131). From several 
animal experiments it can be concluded that serine and glycine are synthesized 
in the cytosol, but serine is actively transported into the mitochondria, where 
the serine concentration is responsible for glycine formation. In contrast to 
SHMT the cleavage enzyme complex is confined to the mitochondria; the two 
iso-enzymes of SHMT are not identical. Methylated folates diffuse passively 
across membranes. 
It can be concluded that the complexity of the serine-glycine metabolism offers 
many possibilities for derangement. Increased pyrrol synthesis, abnormal activity 
of the succinate-glycine cycle, the amino-aceton cycle, the glycine cleavage 
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enzyme, disturbances in active transport of serine and/or (iso)enzymic changes 
can all be held responsible for upsetting the normal regulations of the serine-
glycine balance. 
But at least it is not inconceivable that acute porphyric attacks and starvation as 
well may be powerful stimuli for increased serine to glycine conversion, which is 
interesting in the light of the beneficial effect of the serine-glycine deficient, 
calorie-rich diet on the psychosis of our patient. 
PRELIMINARY HYPOTHESIS 
As stated before, ~ event that will lead to (temporarily) excessive formation 
and piling up of methylenelated folates may induce the formation of formal-
dehyde and hence cyclization of monoamines. 
So whatever the cause, abnormal increased expenditure of glycine which entails 
demethylation of serine, has to be responsible for the psychotic attacks. 
It was argued that in our patient the basic metabolic disturbance is latent during 
'normal' episodes, but that an appropriate induction will stimulate serine to 
glycine conversion to such a measure that methylene trapping will occur. 
Therefore, the assumed abnormal catabolism of serine and glycine might be 
demonstrated even during normal episodes after loading the patient with serine 
or glycine; plasma serine and glycine concentrations after loading might be 
different when compared to control loadings. 
Distinct psychopathological changes identical with those previously experienced 
by the patient during the psychoses, emerged after a low oral dose of aminoacid 
(2 mmol/kg body wt.), thus suggesting that this was a suitable line for further 
study. 
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CHAPTER ll. 
SCHIZOPHRENIA-LIKE PSYCHOSIS CAUSED BY A METABOLIC 
DISORDER" 
L. Pepplinkhuizen, J. Bruinvels, W. Blom, and P. Moleman 
Group Biological Psychiatry, Medical Faculty, Erasmus University Rotterdam, 
Rotterdam, The Netherlands 
Introduction 
Metabolic diseases are often accompanied by psychiatric symptoms-e.g., Wilson's 
disease (!), Hartnup's disease (2), and porphyria (3). We observed some patients 
with a Characteristic psychosis which bore a striking resemblance to a drug-
induced psychosis of the mescaline type. These patients were suspected of having 
a porphyrlc disease, and we wondered whether the metabolic dysfunctions 
occuring in porphyrlc diseases could be related to the psychosis. 
In the porphyrias the increase in pyrrol synthesis demands increasing amounts of 
glycine; hence conversion of serine into glycine is accelerated and excess methyl 
group5 are produced. The availability of excess methyl groups may result in 
faulty methylation of catecholamines (il). 
On the basis of this working hypothesis we studied the serine and glycine 
excretion during and after psychosis and did lociding tests with these aminoacids. 
Subjects and methods 
On admission all patients showed disturbances of affect, were depersonalised, 
and complained of perceptual distortions (1dysperceptions 1) of surroundings, 
colour, and time, and of other types of abnormal sensory perception apart from 
" Published in The Lancet, march 1, 1980, pp. li5li-li56 
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distinct hallucinations (5). None had impaired consciousness or disorders of 
thinking. They werd diagnosed as having schizophreniform psychotic syndromes. 
Four female patients out of ten (3 male and 7 female) were further investigated 
because they did not irr.prove with neuroleptic treatment. 
Patient 1. - She was 24- years old, had had several admissions to psychiatric 
hospitals in the past seven years for symptoms which started after a surgical 
operation under general anaesthesia (including thiopentalsodium)-hallucinations, 
catalepsy, progressive polyneuropathy, and colicky pains. 
Patient 2. - This 18-year-old patient had been admitted for an acute psychosis 
characterised by hallucinations and catatonic symptoms caused by medication 
with a sulphur preparation and barbiturates. She also had abdominal pain. 
Patient 3. - She was 37 years old and premenstrual induction of symptoms was 
observed during each of her four admissions. 
Patient lJ.. - The 27-year-old patient was very dysphoric and had intermittent 
hallucinations. Her symptoms, which included skin lesions, developed after she 
began taking contraceptive pills with a large oestrogen component. 
Porphyrins were measured during and after psychosis in 24. h urine and in faeces 
(6), and aminoacid analysis was done on blood and 24 h urine (7). 
The patients were given a diet rich in carbohydrates (4-05 g/day), moderately low 
in protein (62g/day), and very low in fat (!9g/day), the approximate calorie 
intake being 201f0 kcal/day. 
The patients gave consent for a loading test in which serine or glycine 
(2 mmol/kg) was given I h before breakfast with yoghurt. This trial was done 
double blind after complete recovery from psychosis and with patients on the 
same diet as above. It was done while patients were in hospital and without any 
change in the normal daily routine. Behavioural scoring (see legend accom-
panying table) was done by nurses and two psychiatrists. 
Four healthy controls, matched for age and weight, also underwent the loading 
test. 
The committee on human experimentation of the University Hospital approved of 
these tests. 
Results 
Porphyria 
Since the patients were suspected of having porphyria, a carbohydrate-rich diet, 
known to be of therapeutic value in porphyric disease (8), was prescribed. All 
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patients recovered from their psychosis within 2-5 days of taking this diet. 
In patient 2 the raised faecal protoporphyrin excretion and the presence of 
porphobilinogen in urine on admission suggested porphyria variegata. In patient 4 
the excretion of large amounts of urocarboxylic and heptacarboxylic porphyrin in 
the urine and isocoproporphyrin in the faeces suggested porphyria cutanea tarda. 
In patients 1 and 3 no abnormalities were found upon repeated analysis. 
Aminoacids 
The excretion of serine and glycine was measured in 24 h urine specimens along 
with that of alanine and tyrosine as reference aminoacids (see table). 
During psychotic episodes serine excretion dropped in all patients. In addition 
patient 1 showed an increased excretion of glycine. The porphyric patients 
(2 and 4) had a more general disturbance of aminoacid excretion patterns. During 
remission none of the patients showed any abnormality in aminoacid excretion. 
Homocystinuria was excluded in all patients. 
Loading Tests 
All patients had psychopathological symptoms on serine loading (fig. 1). All 
became depersonalised, and three also had dysperceptions. In addition, patient 2 
became very euphoric and had complex visual hallucinations. Patient 3 became 
very dysphoric, and patient 4 had simple visual hallucinations. The serine induced 
psychosis occurred about 5 h after ingestion of the aminoacid and lasted 3-6 h. 
Glycine had no effect on three of the four patients. 
According to the patients their experiences during the loading test were 
identical with those of their 'natural' psychosis. 
None of the controls reacted to serine or glycine loading. 
Discussion 
The dysperceptions and the hallucinations were highly suggestive of drug-
induced psychosis of the mescaline or lysergic-add type. Since drug-induced 
psychosis was excluded, we thought that hallucinogenic substances could have 
been formed endogenously because of a metabolic dysfunction related to 
porphyria. 
A theoretical relation between porphyria and psychotic behaviour is shown in 
fig. 2. During a porphyric attack the increased formation of porphyrins will 
demand larger amounts of the precursors glycine and succinyl-CoA (9). The 
increased demand of glycine can be met by demethylation of serine (10). During 
demethylation a methylene group is transferred from serine to tetrahydrofollc 
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.., 
EXCRETION OF SERINE AND GLYCINE 0 
Score * No. of Serine Glycine Alanine Tyrosine 
psychotic 
attacks 
Controls (n=4) 0 -- 784+65 1685+233 444+172 123+15 
Patients in remission (n:o:4) 0 
--
788+74 1428+502 250+88 1 01+34 
Patients during attacks 
Patient 3 2 3 211+6 1119+51 325+4 120+12 
-
Patient 3 4 2 146(139;154) 698(781;616) 214(235; 192) 91(86;96) 
Patient 1 5 3 6+6 3382+805 346+117 104+29 
Patient 4 J<:J< 5 1 30 52 50 40 
Patient 2 Jr.Jt 6 1 111 592 81 18 
¥: Scores: anxiety 1; dysphoria/euphoria 2; depersonalisation 3; dysperceptions 4; hallucinations 5; catatonia 6. 
J<J< Patients with porphyria. 
Mean values given for control groups and for patients in remission; aminoacids values in micromol/1 /24 h. 
serine loading ~ 
Behavioural score 
6 
glycine loodinQ 
5 
4 
3 
2 
E.M. A.H. G.B. S.R. 
Fig. 1 - Behavioural score after serine and glycine load. 
See footnote to table for scores. 
acid (FH~). The N5, N10 -methylene tetrahydrofolic acid (CH2=FH~) thus formed 
is an active methylating agent, involved not only in normal methylation 
processes (via the vitamin B12, homocysteine-methionine pathway) but also in 
possible abnormal methylation (R2H -~R2CH3) or cyclisation of monoamines 
(11-13) several of which are known to be psychotogenic substances (1~). 
The decreased secretion of serine in all patients during psychotic periods, 
suggesting increased comsumption of serine, indicated a central role for serine 
and glycine in this syndrome. More direct evidence for such a role was provided 
by the quick and dramatic effects of serine loading on all patients. However, 
since one patient also reacted to glycine loading, the simple hypothesis that 
increased conversion of serine into glycine is responsible for the psychosis will 
not suffice. Also, the relation with porphyria is not clear in all cases - a 
porphyrlc disease was proven biochemically in only two patients. 
Further research in progress with patients having episodic psychosis character-
ised by dysperceptions shows that most of these patients react with (pre) 
~1 
psychotic symptoms on glycine or serine loading, whereas patients with other 
forms of psychosis do not. Some disturbance of serine-glycine metabolism 
therefore seems to be involved in the schizophreniform psychotic syndrome 
described here. 
1 
homocys 
S-Ad-methionine 
r 
---7__,--"'\~--•• methionine 
CHJ-Bl2 Bl2 
ser gly 
----1>8-ALA + 
succi nyl CoA • PBG 
hfme 
Fig. 2 - Porphyrin biosynthesis related to methylation processes. 
Only the first part of the porphyric biosynthesis pathway is indicated: delta-
ALA, delta-aminolaevulinic acid; PBG, porphobilinogen; ser, serine; gly, glycine, 
FH4, tetrahydrofolate; CHz=FH4, N
5
, N10 -methylene FH4; CH3-HF 4, 
N5 -methyl FH4; homocys, homocysteine; S-AD-, 5-Adenosyl-. 
R 1 H- R 1 CH3 indicates normal methylation (e.g., in choline and creatine 
formation). 
R2H-R2CH3 indicates abnormal methylation (e.g., of monoamines). 
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Summary 
Four patients with an intermittent psychosis closely resembling hallucinogenic 
drug-induced states were suspected of having a porphyric disease and were 
investigated for a possible relation between the metabolic dysfunctions of 
porphyria and the psychotic syndrome. Theoretically the link could be in a 
disturbance of serine and glycine metabolism. This theory was supported by 
disturbances in serine and glycine excretion found in a11 patients during psychotic 
episodes. In addition, loading with one low oral dose of serine produced psychotic 
symptoms 5 h later which lasted 3-6 h. One patient reacted to glycine in the 
same way. These findings suggest that disturbed serine-glycine metabolism may 
have a key role in certain schizophreniform psychotic syndromes. 
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CHAPTER lli. 
A PROPOSAL FOR A NEW CLASSIFICATION OF THE UNCLASSIFIED 
PSYCHOTIC DISORDERS. A RETROSPECTIVE STUDY ~ 
L. Pepplinkhuizen, H.R. van Tuyl, G.A. Ladee and J. Bruinvels 
Introduction 
Recently we postulated that an endogenous synthesis of hallucinogenic sub-
stances was likely to occur in some patients whose acute psychotic episodes 
clearly resemble a 'model psychosis' as known to occur after the intake of LSD, 
mescaline or ps~loclbine (1). In these patients a disturbance in the serine-glycine 
metabolism, the ultimate source of one-carbon moieties in the human body, is 
probably the cause for the generation of the psychotic symptoms (!) (2). An 
increased conversion of serine into glycine will result in an excessive formation 
of one-carbon moieties, which may result in an abnormal methylation or 
cyclization of mono-amines, of which several are potent psychotogenic sub-
stances (3). 
Such an increased conversion of serine into glycine is thought to be the result of 
an increased pyrrol synthesis, which also occurs in porphyric diseases. So far 
porphyria could be demonstrated in only 20% of the patients studied (2). 
When - after complete recovery - these patients, with or without porphyria, 
were orally 1loaded1 with a single dose of serine, the characteristic symptoms, 
especially the sensory perceptual distortions, were evoked about 3-5 hours after 
ingestion. A few patients reacted to glycine in the same way. However, other 
patients who had also suffered from acute psychotic episodes, not accompanied 
by disturbances of sensory perceptions, did not react (2). This suggests that we 
are rlealing with a separdte entity of psychotic illness. 
During our further search for similar patients, we realized that we could find 
:1 Submitted for publication 
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them in the broad and ill-defined group of acute psychoses with an overwhelming 
variety of psychotic symptoms, mostly followed by a complete remission. 
The OSM-111 classifies these psychoses as schizophreniform, brief reactive, 
schizo-affective and atypical disorder, negatively delineated as 1Psychotic Dis-
orders Not Elsewhere Classified 1 (4). 
The occurrence of the special phenomena of a distorted sensory perception in 
some of these psychoses makes it possible to put forward a new and rather 
simple nosological approach for the unclassifiable psychotic disorders. 
For the present paper we studied retrospectively the incidence of the anomalies 
of sensory perception and the psychotic states associated with it, in all case 
histories of unclassified psychoses available to us. 
Mater ia1 and methods 
For the present study we collected and studied case histories of patients 
admitted to the psychiatric ward of the University Hospital during the years 
1969-1979 who met the following criteria: 
1. Detailed medical and psychiatric history, including clinical psychological 
reports, available; 
2. Hospital diagnosis in concordance with one of the groups of the Unclassifiable 
Psychotic Disorders (the various diagnoses that are used for this type of 
psychoses in our hospital imply that the criteria for an affective or 
schizophrenic illness or paranoid psychosis were not fulfilled at the moment 
of discharge from the hospital); 
To limit inclusion errors, special attention was pa.id to the following: 
3. Good premorbid functioning; 
4. Acute or subacute onset of psychotic symptoms; 
5. Complete improvement, without signs of deterioration such as affective 
blunting, inertia, etc.; 
6. Re-adjustment to the level of premorbid functioning without neuroleptic 
medication (lithium therapy allowed); 
7. No mental retardation; 
8. No organic factor(s) involved; cases with a deeply disturbed consciousness 
were excluded, perplexity was allowed; 
9. No hard or soft drug use or alcohol abuse. No use of medication that could 
have contributed to the psychotic syndrome. 
In the few cases when patient care and follow-up after discharge had not been 
carried out by our out-patient department, the necessary information to ascer-
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tain diagnosis and/or complete recovery was obtained from attending physicians 
or from the 'Social-Psychiatric Service of Rotterdam'. 
All doubtful case histories were omitted. 
Evaluation and counting of symptoms 
When a patient had been admitted more than once the best reported psychotic 
episode was chosen for analysis. Only unequivocal statements of the patients or 
described symptoms were taken into consideration. 
In studying the case histories special attention was paid to the following aspects: 
1. Statements of the patients concerning changes of sensory perception of 
surroundings (shapes, depth), light, colours, noises, smell and taste. These 
phenomena can cover a whole range from simple intensification of light and 
noises to gross distortion of the surroundings and synesthesias. 
2. Perceptual changes of the stream of time. The subjective experiences 
included the simple acceleration of time passing as well as complex experi-
ences as the running back of time and being frozen in time. 
3. Strange bodily experiences. These cover minor changes of proprioception such 
as numbness, stiff muscles etc. to severe distortion of the body image, such 
as enlargement or shrinking of the head, being completely flat, having no 
legs, being transparent. 
4-. Depersonalization phenomena. To this category belongs autopsychic deper-
sonalization (feeling empty, strange, etc.), derealization (the feeling as if 
surroundings or people have changed, are at a distance etc.), and somato-
psychic depersonalization (my head feels empty, my legs feel as if they are of 
lead etc.). 
Although depersonalization phenomena frequently have a strong 'as if' char-
acter, the somato-psychic depersonalization made careful an.alysis sometimes 
necessary to decide to which category (3 or 4) strange bodily experiences 
belonged. 
To avoid wishful interpretation by the authors only direct statements were 
rated as true. Certain delusions and ideas uttered by the patient can point to 
a disturbed sensory perception but may have another basis as well. For 
instance 'Flowers and colours are so wonderful and have a special meaningt 
may indicate perceptual changes, but the statement can also result from the 
elevated state of mood of a manic patient without any sensory perceptual 
anomaly. The same holds for many hypochondriacal delusions. 
5. Hallucinations (visual, auditory, olfactory, or tactile). Simple and unformeci 
visual ancl auditory hal!urinations were n0t rated when they were of short 
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duration (e.g. short flashes of light, sudden sounds only occurring once). 
6. State of mood (anxious, depressed, elated, ecstatic). Only prevailing state(s) 
of mood lasting at least a day were rated. A sudden erving-fit in an e\::~tf'rl 
patient was not considered to be a sign of depression. 
7. Psychomotor disturbances (slowed down-hypokinetic; agitated-hyperkinetic; 
catatonic). 
8. Bizarre delusions - the delusion of being controlled, or tl1oughts heing knowr 
or read or eventually broadcasted, inserted or withdrawn - were also rated 
when present. 
The many other possible delusions or delusional ideas as delusion of refe-
rence, thought reading, being a powerful person, religious, paranoid and 
hypochondriacal delusions were so rapidly changing and abundantly present 
that counting proved rather superfluous and of little value. So only the 
'suspect' delusions for a schizophrenic psychosis were taken into account. 
9. Formal thought disorders as incoherence, concretism, and neologism. 
A symptom was only counted once, even if it occurred at different intervals 
during the same psychotic period. 
Special interest was also devoted to those cases showing a 'march of symptoms', 
which means a gradual development of psychopathological symptoms, especially 
the appearance and disappearance of certain symptoms during the development 
of the psychosis. 
Attention was also paid to the precipitating factors. Although we tried to 
extract information on family psychopathology from the case histories, this 
proved to be impossible since exact information was often unavailable. 
Statistics 
Fisher's exact test and the Chi-square test were used to test differences between 
groups. 
Results 
To give an impression of the frequency of the psychotic disorders, the numbers 
of admission to our clinic from 1969 till 1979 were: 
organic mental disorders 608 
paranoid disorders 128 
schizophrenic disorders 467 
affective disorders 560 
atypical/unc1assifiab1e psychoses 340 
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It should be noted that these numbers are cumulative, repeat admissions being 
counted. From the 34-0 admissions of the last category, 133 patients were 
selected according to the criteria described in Methods. 
Of these 133 cases, a total number of 62 patients were excluded: 11 were 
deemed to have schizophrenia; 10 ran a chronic course and needed prolonged 
(longer than 6 months) antipsychotic medication after discharge; 5 suffered from 
affective disorders with congruent psychotic features; 14 were judged to suffer 
from other psychoses, mainly paranoid and hysterical psychoses. In 14 patients 
organic factors, ranging from organic cerebral dysfunction such as epilepsy to 
general organic or hormonal diseases were involved. Eight patients were ex-
cluded because of language problems and lack of information. 
On basis of symptomatology it was possible in the remaining 71 patients to 
discern two major psychotic entities and one minor one. 
Twenty-seven patients showed a characteristic sensory perceptual distortion of 
light, colours, sounds, and surrounding spatial world (designated as group 1). One 
patient of this group was reported to have only suffered from perceptual 
distortions of shapes, while a second patient only suffered from a disturbed 
perception of Iig_ht and colours. All other patients were reported to suffer from a 
variety of dysperceptions. 
In 4-4 patients these symptoms W"l're lacking, but in 35 patients (designated as 
group B) distinct depersonalization phenomena were present, which were severe 
in 24- patients. 
Although depersonalization was also present in 11 patients of group A, it never 
dominated the clinical picture as was the case in most patients of group B. 
Finally, a group of 9 patients remained, not showing dysperceptions nor de-
personalization (designated as group C). 
Age, sex, and admission 
No differences were found with regard to sex within or between the three groups 
(an equal sex-distribution for all three groups: group A 13 male and 14 female; 
group B 18 and 17, and group C 4 and 5 respectively). 
The age at the first psychotic episode varied widely in all groups, although the 
mean age for each group did not differ (see Table IA). The risk of a first 
psychotic outbreak seems relatively high in the second and third decade of life 
for group A and B (see Table IB). In addition, no differences were found for the 
mean duration of the index admission between the three groups (see Table lA). 
The mean number of psychotic episodes occurring during the 10 years of the 
study is for group A 2.3; group B !.8, and group C 1.4). 
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TABLE lA 
AGE OF FIRST PSYCHOSIS AND LENGTH OF THE INDEX ADMISSION 
mean age of mean duration of 
first psychosis admission in months 
Group A 28.4 3.3 
(N=27) 01-45)* (1-7}* 
Group B 27.4 2.8 
(N=35) (!5-lfO) (1-7} 
Group C 3!.lf 2.3 
(N=9) (17 -52) (1-lf) 
:.: In brackets the range. 
TABLE IB 
AGE DISTRIBUTION OF THE FIRST PSYCHOSIS 
Years Group A Group B 
10-19 9 
20-29 II 13 
30-39 7 10 
lfO > 5 3 
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Precipitating factors 
In group A, sleep deprivation was considered to be a precipitating moment in 
7 cases, menstruation in 2 cases, and other somatic factors (as operation, and 
somatic illness) in 3 cases. 
For group B the numbers are respectively 4, 0, and 7. 
For the remaining 15 patients of group A and the 24 patients of group B 
stressfull reactive and/or psychogenic moments were considered to be related to 
the outbreak of the psychosis. 
The absence of any exogenous precipitating factor was clearly noted in one 
patient of group A, who had been admitted eleven times. 
Hospital diagnosis 
From Table II it is clear that the favourite hospital diagnosis for group A is 
degeneration psychosis and for group B psychogenic psychosis. 
These are diagnostic concepts based on a typological approximation of form and 
content of the psychoses as observed during admission. They give a good 
impression of subtle differences and distinctions clinicians can make for diag-
nostic purposes, which are difficult to render by other means. 
The differences of these diagnostic concepts are given in relation to the 
discussion of the' new nosological classification proposed here. 
TABLE II 
HOSPITAL DIAGNOSES 
psychogenic degeneration atypical schizo- other 
psychosis psychosis mania phreniform 
psychOsis 
Group A 6* IO** 5 3 3 
Group B 23* •** 2 2 
Group C 6 2 
* chi-square 11.58, p < 0.00 I 
u chi-square 5.72, p < 0.02 
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Symptomatology 
Table III compiles the frequency of the symptoms for the three groups. 
The similarities and differences between the two larger groups A and B are of 
special interest as the number of patients in group C is too small to allow a 
fruitful comparison and discussion. 
No significant differences were found for distortions of body image or for an 
anomalous perception o"f the flow of time. However, from our study of the case 
histories we got the impression that the latter symptom had been often 
neglected during the psychiatric examination due to unfamiliarity with this type 
of symptom. 
As far as hallucinatory experiences are concerned there is a significant pre-
ponderance of visual hallucinations in group A compared to group B (p<O.OOl). 
In group B a negative mood (depression) obviously prevailed (p<0.05). Major mood 
swings (from depressed/anxious to elated/ecstatic or vice versa) were noted in 
all groups. 
Most patients were considered to have shown a hyperactive motor behaviour. In 
addition, it is noteworthy that catatonic features in group A (7 out or 27 
patients) were noted twice in a hyperkinetic patient and once in an akinetic 
patient. The same relationship was found in group B in which catatonia was 
present in 5 patients out of 35. 
So-called suspect symptomatology for a schizophrenic process (formal thought 
disorders and bizarre delusions) was found in all groups. The main groups did not 
differ significantly in these aspects. 
However, in group A this severe psychotic symptomatology was found to be 
present significantly more often in patients also sufferring from a distorted body 
image and/or catatonic symptoms (Table IV). Such a relationship could not be 
substantiated for group B. 
In both groups perplexity does not seem to be related to the severe psychotic 
symptoms. 
March of symptoms 
A march of symptoms could be studied in 8 cases of group A. In these cases the 
development of symptomatology was more gradual instead of fullblown from the 
beginning. 
For four patients a graphic representation illustrates this development of the 
changes in mood and motor behaviour, dysperceptions, distortions in body image, 
bizarre delusions and formal thinking disorders till the first signs of improvement 
(see fig. I). 
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TABLE lll 
MAIN CHARACTERISTICS AFTER CLASSIFICATION INTO THREE GROUPS 
Distorted body image 
Disturbances of time perception 
Visual hallu-
Acoustic cina-
Olfactory + taste tions 
Depressed rn 
Anxious 0 
Elated 0 
Ecstatic d 
Mcxx:l swings 
Bizarre delusions 
thought disturbances 
Perplexity 
Hyperkinesia 
Akinesia 
Catatonic symptoms 
* Chisquare 
"'* Chi square 
11.49 
4.32 
p < 0.001 
p < 0.05 
Group A 
(n = 27) 
l3 
12 
6""' 
9 
18 
9 
7 
ll 
6 
9 
3 
7 
Group B 
(n = 35) 
14 
7 
18""' 
16 
15 
5 
9 
l3 
13 
l3 
4 
5 
Group C 
(n = 9) 
3 
8 
7 
2 
4 
7 
4 
2 
4 
3 
2 
7 
0 
3 
Statistical evaluation of the other symptoms did not show any signifi-
cant difference between group A and B. 
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TABLE IV 
RELATIONSHIP OF SCHIZOPHRENIC SYMPTOMS AND DISTUR-
BANCES IN BODY IMAGE, CATATONIC SYMPTOMS, AND 
PERPLEXITY 
Grou~ A Body Image Catatonic Perplexity 
Disturbances Symptoms 
ab- pre- ab- pre- ab- pre-
sent sent sent sent sent sent 
Schizophrenic eresent 2 9 5 6 10 
Symptoms absent 12 4 15 l! 5 
Chi2 = 6.31 Fisher test Fisher test 
p < 0.02 p < 0.01 n.s. 
Graue B Body Image Catatonic Perplexity 
Disturbances Symptoms 
ab- pre- ab- pre- ab- pre-
sent sent sent sent sent sent 
Schizophrenic 2resent 8 5 l! 2 10 3 
Symptoms absent_ 13 9 19 3 12 10 
Ch/ = 0.046 Fisher test Fisher test 
n.s. n.s. n.s. 
From these 8 cases it can be concluded that the sensory perceptual disturbances 
constitute early symptoms, although they can be preceded by disturbances in 
mood and motor behaviour. Hallucinations have been noted at a later stage and 
could be present throughout the further psychotic episode. In 5 cases visual 
hallucinatory experiences preceded the acoustic hallucinations. A distorted body 
image concomitant with bizarre delusions and/or thought disturbances, occurred 
later on. The finding that in this small number of patients 'suspect' symptoms 
were linked to a distorted body image is in agreement with the general 
conclusion that in patients of group A the severe psychotic symptoms are found 
to go with a distorted body image in one and the same patient. 
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Such a relation between mood and motor behaviour cannot be demonstrated in 
these eight patients. 
A further analysis of the vicissitudes of the perceptual changes is given in 
Discussion. 
A distinct march of symptoms could not be discovered in the patients of group B. 
GRAPHIC REPRESENTATION OF THE MARCH OF SYMPTOMS OF~ PATIENTS 
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weeks 
del = bizarre delusions, th = formal thought disorder, bod = distorted body image, 
hal = hallucinations, per = distorted sensory perception. 
md = mood; + indicates a positive, -indicates a negative state of mood. 
mot = motor behaviour; 0 indicates a normal, + a hyperkinetic I desinhibited and 
-a hypokinetic I inhibited motor behaviour. 
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Dissipation of dysperceptions 
The early presence of dysperceptions during a psychotic episode in patients 
showing a march of symptoms is in agreement with the presence of these 
symptoms during the first two weeks of the psychosis in other patients belonging 
to group A. 
It should be noted that almost all patients had been treated with neuroleptics 
which also may suppress the dysperceptions. 
However, in two patients (nr. 64 and 71) with a march of symptoms who did not 
receive neuroleptics, the dysperceptions disappeared spontaneously. 
In contrast, sensory perceptual distortions were clearly present throughout the 
whole psychotic episode in two patients despite neuroleptic treatment. 
DISCUSSION 
Much attention has been paid to the acute and difficult to classify psychotic 
disorders, since Kasanin's publication in 1933 of what he called the schizo-
affective psychoses (5), although such a group of psychoses had been described 
long before Kasanin (6). 
There is serious doubt whether these so-called schizo-affective psychoses form a 
group of separate psychotic illnesses not related to the two functional psychoses 
(7). 
The numerous studies on this problem of the 'third functional psychosis', start 
from a symptomatological approach, namely a temporary mixture of 'schizo-
phrenic' and 'affective' symptoms, which is regarded as sufficient to classify this 
complex as a psychotic entity (7). 
Genetic, (8-10), family (9-13), and follow-up studies 04-17) subsequently sug-
gested that the group of schizo-affective psychoses is a heterogenous one related 
to the ~anic-Depressive or Schizophrenic Disorders or to both in varying 
degrees. Several authors point out that most of the so-called schizophrenic 
symptoms, when observed together with affective, especially manic, symptoms 
have little value in predicting a chronic deteriorating course, and conclude that 
the patients actually suffer from a manic-depressive illness 08-27). 
In a thorough overview and reassessment of the literature on the specificity of 
'schizophrenic' symptoms, Pope and Lipowski (28) also suggest that the major 
part of the schizo-affective disorders are to be considered as a variant of Manic-
Depressive Illness. 
Few arguments are apparently left to establish the schizo-affective and related 
disorders as the third functional psychosis. 
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Consequently, as most authors regard degeneration (29-31), atypical (32), cycloid 
(33, 34), psychogenic/reactive (35), schizophreniform (36), or schizophrenia-like 
emotional psychoses (37) etc. as simple eponyms of schizo-affective psychoses, 
these diagnostic labels are only of descriptive and limited value. The lack of 
homotypical morbidity among family members (9, 13) and the metamorphosis of 
successive psychotic episodes in individual patients from 'schizophrenic' to 
'manic' (23, 26), are in support of such a point of view. 
It is doubtful whether such a far-reaching conclusion is justified. 
Firstly, in the studies (8-17) of syndromes of schizo-affective psychoses, too 
little attention has been paid to the benign course of the disease, namely the 
complete recovery from a psychotic episode, which is a fundamental charac-
teristic of this type of psychoses. Secondly, specific descriptive-diagnostic 
concepts of these psychoses, as described below, are neglected. 
In the reactive/psychogenic psychoses of McCabe (35) the onset is acute and 
associated with an adequate trauma or emotional conflict that is reflected in 
selfdepreciation, referential ideas and persecutory delusions. The patient is 
depressed, anxious and irritable. Motor activity ls generally normal. Auditive 
hallucinations and first-rank symptoms of schizophrenia occur in a state of clear 
consciousness. More florid symptomatorogy is associated with a perplexed or 
confusional state. 
In the cycloid psychoses of Leonhard (33) and Perris (34) a greater variety is 
found: the syndrome is characterized by mood swings and various degrees of 
confusion, paranoia-like symptoms and/or hallucinations not syntonic with the 
level of mood, motility disturbances, episodes of ecstasy and pananxiety. 
Taking the dinical description into account, the cycloid psychoses are possibly 
the same as the atypical psychoses described by Mltsuda (32) who stresses the 
rapid fluctuations and kaleidoscopic pictures. Delusions and paranoid-hallu-
cinatory experiences are found together with conf""sional or oneiroid states. 
Although McCabe reported that some of his patients had relatives with affective 
psychoses (35, 38), all authors find that the genetic part of their studies 
supported the notion that these groups of psychoses form an independent entity. 
With the above mentioned, more narrow definition of reactive, cycloid and 
atypical psychoses in mind, it is possible to distinguish many of the acute 
psychoses with a favourable outcome from the unclassifiable psychoses. 
However, these diagnostic concepts are still based on a typological approach and 
pathognomonic symptoms supporting a straight classification are not found (39). 
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The present study shows that difficult typological characterization is not 
necessary and that the group of unclassifiable psychoses can be differentiated by 
using simple criteria, into at least two separate groups of psychotic disorders: a 
psychosis characterized by a temporary, distorted sensory perception (group A), 
and a psychosis characterized by distinct depersonalization phenomena without 
these distortions (group B). 
Group A: Psychoses accompanied by distorted sensory perception 
Due to the extensive case notes and the interest of our clinic in depersonaliza-
tion and related phenomena (40, 41) it was possible to identify such a sub-group 
without great difficulties. 
In all patients perceptual anomalies were observed at the start of the psychotic 
period (first and second week), except for two patients who kept complaining 
about distorted perception during the total length of their psychosis. 
If the dysperceptlons are indeed caused by an endogenous synthesis of halluci-
nogenic substances the question arises why these disturbances disappear after a 
few weeks. The only model psychosis comparable to a naturally occurring 
psychotic state is that induced by hallucinogens administered continuously for 
weeks or months (42). From animal studies evidence has been presented for the 
rapid development of tolerance to the inhibitory but not to the excitatory 
effects of LSD and mescaline (~3, ~~), It has been suggested that this inhibitory 
effect is comparable to the rapid development of tolerance to psychedelic 
effects of drugs in man (~2, ~3, ~~). 
Tucker et al. (45) presented some evidence for an increase in pathological 
disturbances of thinking in non-schizophrenic subjects after prolonged use of 
hallucinogenic drugs. This suggests that at least in some individuals, adaptation 
to psychotomimetic effects is lacking. 
Besides the development of tolerance to hallucinogenic substances as a possible 
cause for the disappearance of these early symptoms, the capacity of the CNS to 
adapt to an altered sensory input, has to be taken into account (42). The latter 
can be illustrated by experiments with human subjects making use of prismatic 
or coloured lenses (46). The effect of neuroleptics on these disturbances is 
obscure. 
The altered sensory perception also forms a basis for a highly personal, but 
psychotic interpretation, in which the changes as experienced by the patient will 
be concealed. Thus, one patient stated that she was going to be raped by an ape, 
while it became clear afterwards that she experienced the persons around her as 
dark hairy-like individuals resembling apes. The statement of another patient 'I 
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am in paradise, was based on the perception of magnificent intensified colours, 
as told by this patient afterwards. 
Besides, in this tota11y altered mental state otherwise repressed intrapersonal 
conflictuous and primitive drive material is released (47) and can be so 
overwhelming for the patient that other experiences are suppressed. 
It is conceivable that the experienced perceptual changes are less and less 
directly mentioned by a patient after continuation or worsening of the psychosis. 
It is likely that these perceptual changes may become interwoven with, and 
partly constitute, the actual content of the psychosis. 
In order to identify this type of psychosis, it is therefore of paramount 
importance that patients be questioned about sensory perceptual disturbances. 
The march of symptoms 
Some of the psychoses from group A (8 out of 27) were found to have a gradual 
development of symptomatology. The recognition of such a march of succeeding 
stages, each with its characteristic symptoms, may have several advantages. 
Previously (1, 2) we used a scheme adapted from Fisher (48) which encompassed 
a gradua11y developing symptomatology with the sequence of anxiety, dys-
phoria/euphoria, depersonalization, dysperceptions, hallucinations and catatonia, 
while delusions, negativistic behaviour etc. were considered as secondary phe-
nomena which had no direct impact on assessing the severity of the psychotic 
illness. 
Further studies have made it clear, however, that this scheme is rather 
oversimplified and is often not applicable. From a phenomenological point of 
view, disturbances of mood are not of the same order as disturbances in 
perception or motor behaviour, although they may be closely related. Bizarre 
posturing may be the consequence of the perception of severely distorted 
surroundings as a lack of vision of depth, but such a distorted perception may 
occur without bizarre posturing in other patients. Positive changes in mood may 
be associated with hyperactive motor behaviour, as for instance in a manic 
syndrome, but the opposite can also be demonstrated. The experience of speeding 
up of the stream of time is mostly accompanied by a cheerful, elated mood and 
hyperkinetic behaviour, but some patients may be completely akinetic and 
apprehensive although they experience the same acceleration of the passage of 
time. As has been observed for personality factors involved in LSD-induced 
states (49), cognitive and biological factors may also influence and shape such a 
temporary combination of symptoms. 
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Therefore, we have looked more carefully into the categories of psycho-
pathologic changes which we thought to be of fundamental interest to understand 
the diversity of the clinical pictures observed. 
We did so for the basic disturbances in a) sensory perception, b) time perception, 
c) mood and d) motor behaviour. 
a) Sensory perception. 
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From the detailed clinical descriptions of the patients with a march of 
symptoms, we can compose within the category of sensory perceptual 
disturbances,. the following sequence of psychopathological phenomena as 
they emerged during the progression of the psychosis: 
l. Perceptual changes of light, colours, sounds, taste, proprioception. 
2. Perceptual changes of the surrounding spatial world. 
3. Visual hallucinations. 
4. Auditory hallucinations. 
5. Gross disturbances of the body image, that result from extreme distur-
bances of proprioception. 
Of this sequence, the symptoms mentioned under l. and 2. tended to 
disappear while the remaining symptoms could be observed during the whole 
psychotic episode. 
From the material studied we tentatively conclude that an increasing 
visualization, such as dosed eye imagery, more vidid and colourful dreaming, 
eidetic memory and finally visual hallucinatory experiences, occured at the 
cost of conceptual thinking. Conceptual thought can be completely per-
ceptualized with the impossibility to understand and to give logical infor-
mation. Logic thinking is blocked, concepts become percepts. 
One example may suffice: A patient was asked from what angle he looked at 
his problem. It turned out to be impossible for him to understand the 
figurative meaning of this phrase, because he saw images in which he was 
fishing ('angling') and he gave some seemingly non-sensical answers. Although 
such a relationship is not always so dearly understandable, the results show 
that a distorted body image can be associated with formal thought disorder 
and/or bizarre delusions. 
The impairment of the conceptual world at the cost of perceptualization 
makes it tempting to speculate that an increasing activation of the non-
dominant cerebral hemisphere is responsible. Such a mechanism has been 
suggested to explain the symptomatology of hallucinogenic drug-induced 
states (1;2). 
The high incidence of auditory hallucinations in group A may contradict the 
hypothesis that the endogenous synthesis of hallucinogenic compounds is 
responsible for this type of psychosis, since the use of a hallucinogenic drug is 
mostly associated with visual perceptual phenomena. However, Young (50) 
reported a high incidence (30%) of auditory hallucinations in LSD-induced 
states. 
b) In the same manner we studied the experiences of the passage of time. 
A distinct sequence of abnormal perceptions of time was not observed in our 
material. Nor was it evident that the more bizarre disturbances of time 
perceptions were related to the more severe disturbances in sensory percep-
tion. As mentioned under Results, the data of these disturbances are 
insufficient to draw conclusions. 
c) A gradual development of mood disturbances from depression, anxiety to 
euphoria, elation and finally ecstasy, has not been noted. The changes in the 
state of mood seemed to occur abruptly (mood swings). 
d) The same applies to motor behaviour. Hyperkinetic and catatonic features 
dominated the clinical picture in the individual patient. Extreme hypokinesia 
(akinesia) was seldom noted. 
When catatonia was present it was noted to occur in the more severely 
psychotic patients belonging to group A, while this correlation was lacking in 
patients of group B. No other clearcut relationships with sensory perception 
or mood could be found. 
Although it was not possible to demonstrate either a relationship between mood 
disturbances and motor behaviour, and the sequence of sensory perceptual 
distortions or a predictable development of symptomatology within these cate-
gories, the presence of these disturbances is very relevant to the often confusing 
diagnostic excercises in the group of unclassified psychoses. 
Cognitive changes 
The effects of these changes are far-reaching. A new cognitive restructuring and 
re-appraisal of the changed inner and outer world has to take place. Many 
patients, mainly those characterized by the diagnosis 1degeneration psychosis 1, 
may experience objects and happenings as having new and special meaning, they 
have become symbolic or allegoric, refering to a divine cause which only the 
patient is able to grasp. Past and future can merge into an all encompassing 
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experience of one-ness. It is a rich, mythical experience, comparable to that 
induced by hallucinogenic drugs. 
During progression of the psychosis many, mostly perfunctory, bizarre ideas and 
delusions arise. 
In order to adapt to and comprehend the dramatically changed stream of 
information from the outer, but also from the inner world, ideas and delusions of 
reference, grandiosity, hypochondria etc. may develop. Consequently, delusions 
will not be of primary but most probably of secondary derived nature. 
One of the patients experienced that suddenly time came to a standstill and 
started to run back. Thus this patient developed the delusion that he was 
immortal and would go back in time untill the birth of the universe and then 
would live with God. In order to stop this process in a very concrete manner he 
annihilated Time by destroying the ward clock. 
However, when the fundamental changes are very severe and/or the cognitive 
abilities of the patient are poor, such an adaptation is likely to fail, leaving the 
patient perplexed. 
In relation to the march of symptoms it is interesting to note that bizarre 
delusions such as being able to read thoughts or having one's thoughts read and 
sometimes thought sharing and broadcasting were also observed when the final 
stages of the perceptual scheme ( 4. and 5.) were present. Body and ego 
bounderies are broken down simultaneously. 
In general it can be stated that a more florid and even suspect schizophrenic 
symptomatology belongs to the final stages. 
The composition of different psychotic states 
Based upon the basic psychopathological changes (perception, time, motor 
behaviour, mood) it is possible to reduce apparently different psychotic states to 
the same denominator. Different psychotic states appear as a resultant of 
changes in the composition of the basic psychopathology. 
This can be illustrated by the following examples: 
During her first admission a patient showed an (atypical) manic syndrome. She 
had delusions of grandeur with rapid speech characterized by loose associations. 
According to her, everything went very fast due to an acceleration of time. 
Everything around her appeared happy and gay, light and colours seemed very 
bright and objects showed beautiful, coloured outlines. During her second 
admission she was very anxious, complained of strange bodily experiences and 
suffered from hypochondric fears. She felt that everybody knew exactly what she 
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was thinking. Time had slowed down, but in contrast everything outside her was 
moving very fast. In addition, bizarre motor behaviour was observed as well as 
concretistic statements. A schizophrenlform psychosis was diagnosed. Although 
there was no remark suggesting a distorted perception of colours, sounds, and 
surroundings, she mentioned afterwards that before her admission everything had 
been enveloped in a red fog. 
A patient became perplexed when a mixture of rich hailucinatory experiences 
together with akinesis and a very rapid passage of time was present. This clinical 
picture favoured the diagnosis of an onelroid state. However, a later psychotic 
episode of the same patient had been labeled as atypical mania. 
In another patient anxiety, dysperceptions, depression, and hypochondr ic fears 
emerged after the death of a beloved person, due to cancer. The diagnosis of 
psychogenic psychosis was therefore made. 
In conclusion, a 'classic' diagnostic label does not guarantee that the psychosis of 
the patient is neither variable nor reproducible. It follows that the diagnosis of 
acute psychoses according to current criteria will not result in a homogenous 
group of patients. 
The most frequently used diagnosis in this cross-sectional study was degeneration 
psychosis. In our clinic this type of psychosis is characterized by mythical 
experiences, ecstatic feelings, often with sudden changes of mood. Multiple 
perfunctory delusions and hallucinatory experiences are present. The contents of 
the psychosis are often not related in a clearly 'understandable' way to preceding 
conflicts, psychotraumas etc. 
The clinical picture as a whole can be described as kaleidoscopic and poly-
morphic and is in our opinion identical to Mitsuda's atypical psychosis or 
Leonhard's cycloid psychosis, especialJy the anxiety-happiness psychosis (33) and 
the ancient 'boufft~e delirante' (51). 
Group B: Psychoses without a distorted sensory perception 
As a result of the creation of group A a second group, group B, emerged. In these 
patients a distinct and often severe depersonalization was found to be a striking 
feature. It is not inconceivable that this group also constitutes a homogenous 
entity. The most common diagnostic label in this group of patients was 
psychogenic psychosis, which may be indicative of a homogenous entity. Al-
though in group A depersonalization was also noted, it was not found to be such 
an all pervading state as in group B. 
The clinical picture of group B, especially the delusional contents, is more 
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stable. The terms unpredictable, polymorphic and kaleidoscopic do not apply to 
this type of psychosis, hence the diagnosis degeneration psychosis is seldom 
found in this group. 
In accordance with the definition of a reactive psychosis by McCabe (35) the 
contents of these psychoses were clearly related in a more understandable way 
to preceding emotional turmoil. 
Significantly less visual hallucinatory activity was found, whereas disturbances in 
time perception and especially changes in body image were not significantly 
different from those found in group A. 
These findings are in agreement with those by Freeman and Melges (52), who 
showed that in acute psychoses self-estrangement (comparable with our auto-
psychic depersonalization), and disturbed time sense are mutually dependent 
phenomena. 
The disturbances in body image of this group can not be understood as based on 
disturbances in proprioception. In a state of depersonalization, perception itself 
is intact, but the incoming information is detached, dissociated from the 
normally attendant feelings, memories, body scheme etc. It is the apperception 
that is failing. But this will finally result in an identical symptomatology as 
encountered in group A. Not only the own body will appear to be changed, but 
also in this group all incoming information can become so uncommon and 
strange, that it will result in a complete state of perplexity which, as we noted, 
is mostly accompanied by a misrecognition of individuals. Perhaps other clini-
cians will diagnose a state of confusion, but we agree with Cutting et al. (53) 
who separate these superficially identical states, because of the connotations of 
the term confusion with the organic brain syndromes. 
In contrast to group A there are no indications that the more severe psychotic 
symptomatology (disturbances ln body image, 'schizophrenic' and catatonic 
symptoms) are concentrated in individual patients. 
Although positive mood states are also present in group B, feelings of depression 
significantly dominate the clinical picture. Mood swings are also found in this 
group. According to the case notes, the diagnosis of an atypical form of 
(manic-)depressive psychosis has been often considered. 
We have no certainty that this can be ruled out. It is possible that this group is 
genetically related to the bipolar affective disorders. The available data on 
familiar diseases are too weak to confirm or to refute this possibility. However, 
the non-congruency of typical delusions and hallucinations with the state of 
mood, as occurs in psychotic depressions (melancholia), apparently favoured the 
final diagnosis of psychogenic psychosis. 
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CONCLUDING REMARKS 
Anomalous sensory perception and psychedelic experiences have attracted much 
attention in relation to the psychopathology of schizophrenia (5"-57), undefined 
acute psychotic states (58), and hysterical psychoses (59). This resemblance is 
partly responsible for the idea that a hallucinogenic drug-induced psychosis could 
be an appropriate model for schizophrenia. As postulated by Osmond and 
Smythies a metabolic fault, e.g. the dysmethylatlon of mono-amlnes, could be 
the cause of schizophrenia (60). Up till now no solid proof has been found for 
such a hypothesis. 
The same idea has found too little consideration in the groups of episodic 
psychotic illnesses, which is undoubtedly the result of the fact that for a long 
time schizo-affective and related disorders were considered variants of schizo-
phrenia, while nowadays they are considered variants of manic-depressive illness. 
The obvious heterogenity of this group of psychotic disorders seems in a large 
measure responsible for the confusion. 
However, in our opinion at least one group of acute psychotic psychoses with 
complete recovery (group A) can be distinguished as a separate entity. 
Group A is characterized by sensory perceptual distortions and shows in general 
a kaleidoscopic, polymorphic clinical picture. 
A second group (B) lacks these features and is characterized by profound 
depersonalization, a more depressed mood and further a less wild, more 
monomorphic clinical picture. 
Close to our devision in A and B, are the ideas of Roth (61) on schizo-affective 
psychoses. He also reported that two groups of schizo-affective psychoses can be 
distinguished. His first group is characterized by a short-lived schizophreniform 
illness. He relates these psychoses to the phobic-anxiety depersonalization 
syndrome which is known to occur as a reaction to calamitous, stressful events in 
anxious, oversensitive, selfconscious patients lacking in self esteem and suffering 
from varying degrees of phobias. Most of the patients of the phobic-anxiety 
depersonalization syndrome suffer from various degrees of depersonalization and 
37% of 135 patients had 'temporal lobe features' (62), which include the sensory 
perceptual anomalies and time sense disturbances described for group A in the 
present paper. According to Roth the remaining group has much more in common 
with the bipolar affective disorders. 
The current classifications of the psychoses with an acute onset and benign 
65 
course are based upon rather complex diagnostic concepts with all their 
disadvantages. 
The classification presented here offers the possibility to disregard these 
difficult diagnostic concepts, which are often hard to replicate in practice. The 
17 patients in group A with another label than degeneration psychosis would go 
unnoticed, a number far too large to be overlooked. 
In conclusion, we can state, .that the positive identification of one group of 
psychoses characterized by sensory perceptual distortions simplifies and im-
proves the classification of the 'unclasslfiable' psychotic disorders. 
SUMMARY 
We restudied the case histories of all patients admitted to the University 
Hospital Dijkzigt Rotterdam (1969-1979) and belonging to the group of 'unclas-
sifiable psychoses' in an attempt to define a homogenous group of psychoses 
within this broad and poorly delineated category of disorders. Only those 
psychotic states were included, which exhibited distorted sensory perceptions 
resembling hallucinogenic drug-induced states, disregarding the current typo-
logical characterization of the clinical picture. 
Twenty seven patients out of 71 presenting acute psychoses with complete 
recovery, were found to show clearly the desired characteristics. Insight in the 
composition of the diverse clinical pictures on a phenomenological basis has been 
obtained. Many psychotic states of this group showed a clinical picture that can 
be described as polymorphic and kaleidoscopic, previously reported in the 
literature as 'bouffee delirante' (51), atypical psychosis (32), and cycloid psy-
chosis (33). 
A second, slightly larger group emerged, characterized by profound depersonali-
zation and further by a depressed mood and more stable clinical picture. This 
group may be related to the affective disorders, although for several reasons the 
label psychogenic/reactive psychosis seemed more appropriate. 
This classification may prove to be useful in many fields of investigation but at 
present the main focus of the authors' studies is the endogenous formation of 
hallucinogenic substances by metabolic disorders in acute non-schizophrenic 
psychoses. 
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CHAPTER IV. 
INDUCTION OP PSYCHEDELIC AND PSYCHOTIC SYMPTOMS BY ORAL 
SERINE AND GLYCINE LOADING IN PATIENTS WITH EPISODIC 
PSYCHOSES. A DOUBLE BLIND STUDY ~ 
L. Pepplinkhuizen, H.R. van Tuyl and J. Bruinvels 
INTRODUCTION 
Previously we described four patients suffering from an acute schizophreniform 
psychosis characterized by multiple sensory perceptual disturbances, who re-
acted with typical symptoms of distorted perception, depersonalization and 
i 
changed state of mood after oral administration of a single dose of serine 
(2 mmol/kg body wt.). One patient also reacted to glycine (I). 
We suggested that in these patients the psychosis was due to a disturbance of 
serine-glycine metabolism, yielding great quantities of one carbon moieties, 
which may react with monoamlnes to form hallucinogenic substances. Cycliza-
tion of monoamines producing beta-carbolines and isoquinolines, several of which 
have psychotogenic properties, is now thought to be more likely than faulty 
methylation (2, 3, 4-). This cyclization of monoamines is thought to be the result 
of a non-enzymatic condensation of formaldehyde with monoamines. 
Other patients were clinically recognized by the presence of the sensory 
perceptual anomalies (dysperceptions) which are identical with the distorted 
perceptions experienced during hallucinogenic drug-induced states. 
The acute onset and the benign course of the psychoses, with complete recovery 
after each episode, are also distinctive of this group. In addition, many patients 
did not seem to respond favourably to neuroleptics but improved on a high 
carbohydrate, low protein and low fat diet (5). 
;t Submitted for publication 
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To demonstrate the assumed disturbance in serine-glycine metabolism it was 
predicted that such patients, after recovery from their psychosis, would react 
with hallucinogenic drug-like symptoms after administration of serine 
(2 mmol/kg body wt.). 
In this report we present the clinical findings of serine, glycine and glucose 
loading tests performed in a double blind fashion in several categories of patients 
who had suffered from acute psychotic episode(s) with and without distortions of 
sensory perception. 
MATERIAL AND METHODS 
General design of the loading test 
The loading tests were performed on the ward after complete remission of the 
psychosis had been established with the exception of group 2b, representing 
schizophrenic patients in the residual phase. 
The patients had not taken psychotropic medication for at least two weeks, 
except that concomitant use of lithium was allowed in some. 
For each patient three powders were prepared, one with serine, one with glycine, 
and one with glucose. In some patients glucose was replaced by L-methionine 
and/or L-alanine as indicated in Results. Doses were fixed at 2 mmol/kg body 
weight. 
The powder was dissolved in yoghurt and given before breakfast. Patients lay on 
their right side for 30 minutes to increase gastric emptying and the rate of 
absorption.. 
The loading tests were performed double blind, patient, psychiatrists, and nursing 
staff, being unaware of the sequence of administration of the test substances. 
Therefore the patient was observed during the whole day. After norma! be-
haviour was established, after one or two days rest, another powder was 
administered. 
In most patients the loading tests were performed while they were on a constant 
high carbohydrate, low fat, low protein, diet. The amounts of serine and glycine 
in this diet have been calculated (2,3 and 2 gram respectively), in order to study 
the serine-glycine conversion by means of hourly blood samplings. The results of 
these analyses will be published separately. 
For a group of 21 patients (la) the code of the sequence of administered powders 
was broken after all these patients had completed the trial. Otherwise the code 
was broken after each individual trial. 
7~ 
Selection of patients 
Three main groups of patients have been distinguished: 
Group la: 21 patients admitted and observed in our hospital for an acute 
psychosis who showed complete recovery. The diagnostic criteria for an af-
fective, schizophrenic, or paranoid disorder were not fulfilled in these patients. 
According to DSM-III criteria most of them fit into one of the sub-categories of 
Psychotic Disorders Not Elsewhere Classified. In addition, these patients all 
suffered from sensory perceptual distortions such as of light, colours, sound(s), 
shapes, vision of depth, during or previous to the psychotic episode. These 
patients were predicted to react with characteristic psychopathological changes 
to a serine load, performed after complete recovery of their psychoses. 
Patients with organic factors like porphyria which may be causally related to the 
psychosis, were not excluded from this trial, unless clouding of consciousness 
(e.g. delirious states) was a central feature. 
Group lb: the patients complied with the same diagnostic criteria as those 
mentioned under la, but were admitted after the first trial of 21 patients (la) or 
had been admitted and observed elsewhere. In the latter case the perceptual 
anomalies were retrospectively assessed. These patients were also predicted to 
react to serine. 
Group 2a: patients having suffered from acute psychoses with complete recov-
ery, who had also shown sensory perceptual distortions. However, a pathogenesis 
other than a disturbed serine-glycine metabolism was held responsible for the 
psychoses. They were diagnosed as suffering from: minimal brain damage, 
tryptophan malabsorption, temporal lobe epilepsy, LSD-abuse, and borderline 
state. These patients were predicted not to react. 
Group 2b: patients suffering from a residual (defective) schizophrenic state, but 
who during an acute episode ('Schuh') had reportedly shown disturbances of 
sensory perception. They were also predicted not to react to serine. 
Group 3: acute psychotic patients, who gained full recovery, but had not 
exhibited the perceptual changes. Organic psychoses were excluded. These 
patients were predicted not to respond to the serine load. 
Group 4: 15 healthy persons (students and nurses) without a personal or a family 
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history of psychoses, were loaded. 
All patients had had a routine laboratory investigation of hepatic and renal 
function, blood cell counts etc. Blood plasma levels of folic acid, vitamins B 1, 
B6, B12 were determined to exclude deficiency. During the psychotic episode 
porphyrin and porphobilinogen excretion in urine was measured. 
As soon as the clinical condition made it possible, electro-encephalography was 
performed. 
Observation of patients during the loading tests 
The Ethical Committee of the University Hospital Rotterdam 'Dijkzigt' agreed to 
the test as described above. Patients who consented to participate were 
informed in a general way, stating that a mental change might possibly occur 
without emphasizing any specific psychopathological symptomatology in order to 
prevent mduction and unnecessary apprehension. 
f o prevent a laboratory-like observation method, which may considerably 
influence the outcome (6), the physicians and nurses tried to observe as 
inconspicuously as possible. The daily routine of the patients, like creative 
therapy, reading, short walks, etc. was interrupted as little as possible. 
When any change was observed, the patient was encouraged to report it openly. 
When necessary the patient was reassured about the symptoms and their 
duration. Every reaction reported or observed was noted as well as the moment 
of the first symptoms and the lenght of the reaction. 
In a semi-structured interview after each loading day, the changes were assessed 
and the patients completed the Experiential World Inventory of El Meligi and 
Osmond (7), which most of them found helpful to compile their experiences. 
To comprehend the manifold results, a scheme slightly adapted from Snyder and 
Lamparella (8) has been used, covering all phenomena observed (see Table I). 
Only those patients showing distinct psychopathological changes were considered 
positive (see Results). 
RESULTS 
The results of the positive reactions after serine or glycine loading are compiled 
in Table I. When different reactions were observed to both aminoacids of after a 
repeated loading test later on, the strongest is found in the table. 
P 1-~ are the patients described previously(!). 
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P 5-16 are patients from group Ia, P 17-22 are from group lb. 
c1 and c2 are patients (from group 3) showing effects, but were not predicted to 
do so. 
General characteristics of the patients showing psychopathological changes after 
serine/glycine loading. 
The mean age of the first psychotic episode was 24 years, the range 15 to 
47 years. The average duration of the index admission (=last admission before 
loading) was 3.1 months (range 1-12 months). The mean number of psychotic 
episodes of these patients was 2.9 (ranging from 1-10). The mean age at which 
the first loading took place was 27.6 years (range 18-48 years). 
Fifteen out of 24 patients were women. Hospital diagnosis at discharge varied: 
degeneration psychosis was diagnosed in 10, schizo-affective and other psychotic 
states in 7, psychogenic psychosis in 4 and schizophreniform psychosis in 3 
patients. These hospital diagnoses are discussed elsewhere (9) in relation to the 
problems of the Unclassifiable Psychotic Disorders (DSM-III). 
The 'spontaneous' psychoses often followed an emotionally stressful period. It 
should be noted that during such periods lack of sleep and poor appetite are 
commonly reported. In addition, in 5 patients a period of voluntary starvation 
(slimming diets) preceded the outbreak of the psychosis (P 5, P 6, P 14, P 16 and 
P 17). In three women the psychosis started during the premenstrual period (P 3, 
P 22 and C 2). 
Plasma vitamin levels and renal function were found to be within normal limits 
in all patients. An abnormal discharge pattern of temporal lobe origin was found 
to be present in patients P 8 and P 12. 
The interference of organic factors in some patients (P 2, 4, 12 and 18) with 
their psychoses and loading tests will be discussed below. In all other patients 
normal liver function tests were found. 
The serine and glycine-induced reactions 
As can be seen from the table I the types of reaction differed widely among the 
patients. Different responses were observed in those patients who underwent the 
loading test procedure for a second time after another psychotic episode (P 4, 
P 6, P 12, P 16). Three patients (P 9, P 15, P 20) did not report changes in 
sensory perception. Six patients showed only psychopathological sequela after a 
glycine load (P 5, P 9, P 13, P 17, P 18, P 21). Three patients (P 1, C 1 and C 2) 
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reacted lo serine as well as to glycine. 
As far as can be concluded from the present results, lithium administration in 
P 13, P 17 and P 22 and the diet in P 1-9 and P 12-17 (as mentioned under 
Material and Methods) did not impair or alter the evoked reaction pattern in 
comparison with the other positive loadings. 
The first signs of the reaction were observed between 2 and 5 hours after 
administration of an aminoacid; the reaction itself lasted at least 3 hours, but 
always subsided the same day. In many patients the reaction developed along a 
clearly recognizable pattern: the patients first complained of warmth, dizziness, 
lightheadedness, or nausea. Wide pupils, reddened faces and sweating were seen. 
This was followed by sensations of estrangement and depersonalization, being 
unstable, feeling heavy or light and the idea that time was speeding up or slowing 
down. After this, distinct disturbances in sensory awareness of light, colours and 
sounds emerged, and finally an anomalous perception of contours, shapes etc. and 
disturbances in proprioception. Mood had by then became elated or anxious/ 
depressed. 
In a few patients enhanced imagery, like vivid closed eye imagery and hallucina-
tory experiences were observed at the height of their experience. Personality 
factors, anticipation, previous experiences gave form to the ultimate pattern 
(see Discussion). 
Reactions to Glucose, Alanine and Methionine 
One patient out of group la showed a distinct reaction pattern beginning three 
hours after administration of the powder and lasting for six hours. Strong motor 
inhibition, slurred speech, anxiety, paranoid ideas were observed next to sub-
jective reports of a slowing down of the experience of the flow of time and 
extreme depersonalization. 
Code breaking revealed that glucose had been given that day (blood analysis 
confirmed this), no reactions were noted to serine and glycine. 
Almost 30 percent (10 out of 31) of the patients who were predicted to react, 
complained during (a) loading day(s) about feelings of apprehension and showed 
vegetative symptoms like perspiration and stomach ache on powders that 
otherwise did not evoke mental or perceptual changes, and therefore were not 
considered to be responders. 
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Five serine positive patients were subsequently loaded with L-alanine and two of 
them also with L-methionine. The glucose responsive patient also underwent 
both additional loadings. 
No reaction was observed after loading with alanine, and, though no mental 
change was observed after methionine, the patients complained to a varying 
degree about feelings of sickness and warmth, were perspiring and some had an 
ill-looking, greyish complexion. Therefore we decided to stop further me-
thionine-loading tests. 
The loading tests of the control groups 
The results of the loading tests of the different groups of control patients and 
healthy subjects are summarized in Table II. Two patients of group 3 (denoted 
C I and C 2 in Table I) reacted strongly to serine and also (although less 
dramatically) to glycine. None of the other patients reacted, though several 
patients felt tense and showed concomitant vegetative symptoms during loading 
days. 
Two patients of group 2a, suffering from a temporal lobe epilepsy and a 
borderline state respectively, and a manic-depressive patient of group 3 were 
also loaded with double and triple doses of aminoacids, without result. 
A patient suffering from residual schizophrenia and a hebephrenic patient were 
also loaded with L-alanine and L-methionine. 
Vegetative symptoms were noted after methionine and no reactions after 
alanine. 
The Incorrect Predictions 
Thus, nine patients (group 1 a) were incorrectly predicted. A retrospective and 
follow-up investigation made clear why six of these patients were erroneously 
included in group la (see Discussion). 
Incorrect negative predictions occurred in two subjects from control group 3 (C 1 
and C 2 in Table I). 
Most errors in this respect were made during the first years of our study 
(1978/1979), also being the years during which the loadings of group Ia took 
place. Only one patient was wrongly predicted during the period 1980/198]. 
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TABLE ll 
CONTROL LOADING TESTS 
Group Number Hospital diagnosis Reported Number of 
dysper- responsive 
ceptlons patients 
2a minimal brain damage + 0 
2a tryptophan malabsorption + 0 
2a 1 temporal lobe epilepsy + 0 
2a LSD-abuse + 0 
2a borderline state + 0 
2b 4 residual schizophrenia + 0 
3 2 hebephrenia 0 
3 6 manic-depressive illness 0 
3 5 atypical mania 1 
3 6 psychogenic psychosis 
3 4 hyster leal psychosis 0 
3 1 alcohol hallucinosis 0 
15 healthy controls 0 
Total 48" Total 2 
" mean age 27 year (range 17 -45) 
'Spontaneous' loadings by food-stuffs 
A 'natural' loading was observed ln patients nr. P 1 and P 5. The first patient 
became psychotic twice after eating herring and french frieds with mayonaise, 
the other patient after having consumed a large quantity of peanuts. Herrings 
and peanuts are rich in serine and glycine. (100 grams of herring contain 947 mg 
serine and 1062 mg glycine; 100 grams of peanuts 1460 and 1620 mg respec-
tively). 
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DISCUSSION 
The hypothesis that hallucinogenic substances can be rather simply synthesized 
endogenously by a faulty methylation of monoamlnes was proposed by Harley-
Mason, Osmond and Smythies (10). The many similarities between hallucinogenic 
drug-induced states and some types of schizophrenic psychoses make this 
hypothesis attractive. Numerous efforts to prove this hypothesis have been 
published, varying from the detection of an abnormally methylated monoamine 
(3.4-dlmethoxyphenylethylamine) in urine (11, 12), to experiments in which an 
excessive dose of a methyl-donor was administered to chronic schizophrenic 
patients in order to stimulate the assumed aberrant methylation (13). In this and 
later reports the methyldonor methionine was given daily for a prolonged period 
of time. Although a psychotic reaction did occur in several patients, the exact 
nature of the psychotic reaction was not dear. A toxic psychosis superimposed 
upon the residual schizophrenic state, but also the emergence of typical 
schizophrenic symptomatology could be observed in schizophrenics (lt,.). 
In most studies a MAO inhibitor was used. With administration of the methyl 
donor only, a reaction was reported in 40% of the patients (14). In a study of 
Antun glycine was used as a control aminoacid. Reactions were not seen (15). 
Serine was not used in these experiments, although the role of serine as an 
ultimate source of carbon units was known at that time (16). 
Only recently the possible role of serine in aberrant one carbon metabolism has 
been emphasized (17, 18). In vitro serine hydroxymethyltransferase (SHMT) is 
capable of forming tetrahydro-beta-carbolines from tryptamine (19). 
There is evidence that these substances are psychoactive compounds in the 
mammalian body, and some of the derivatives found in plants are hallucinogenic 
compounds (20-2o). The latter finding is of great interest in the light of our own 
experiments with patients. 
It can be expected that an increased conversion of serine to glycine by the 
enzyme SHMT will occur during periods of excessive pyrrolsynthesis, as occurs in 
porphyria, and subsequently will increase the formation of N5N10 -methylene 
tetrahydrofolate. This can result in an oversaturation of the normal folic acid-
B12 pathway to homocysteine as the methyl accepter. It was postulated that 
under such circumstances the transport of one-carbon units could be shifted 
towards formaldehyde synthesis and excessive and possibly abnormal beta-
carboline synthesis (1,5). 
However, only two out of four patients proved to suffer from porphyria. This led 
us to extend the hypothesis to the notion that in all acute psychotic patients with 
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the characteristic symptoms, an excessive formation of N5N10 -methylene tetra-
hydrofollc acid was responsible, due to a disturbance of serine-glycine metab-
olism. To demonstrate such a disturbance the patients who had recovered were 
orally loaded with serine, glycine or glucose (1). 
To our surprise the characteristic symptoms were already evoked a few hours 
after one single loading of serine and/or glycine. Instead of glucose, L-alanine 
was administered to some patients, in order to exclude the possibility that a 
release of NH3 was responsible for the reaction observed. No reaction could be 
observed. It is unlikely that the symptoms could be attributed to a NH3 
intoxication in view of the small quantities of NH3 that will be synthesized from 
such a low dose and the capacity of the liver to convert ammonia to urea. 
Besides, the symptoms of NH3 intoxication are different to those of a hallucino-
genic drug-induced state. 
The responsive patients 
The patients who reacted to serine, glycine, or both, recognized almost immedi-
ately the changes and found them identical or similar to the changes experienced 
during, but especially at the onset of their psychosis. Some worried about the 
possibility of a full relapse. 
As can be seen from Table 1, no uniform reaction pattern emerged for all 
patients. This is hardly surprising in the light of what is known about the 
different ways different personalities react to hallucinogenic drugs (25, 26). 
Most patients did complain about sensory perceptual distortions, which is in 
complete agreement with out expectations. 
In those patients who clearly showed a psychopathological reaction but without 
any reported distorted perception a placebo reaction should also be considered. 
Two out of three patients not showing sensory perceptual distortions (no. P 9 af)d 
P 15) are known to be rigid, with very strong primitive ego defences such as 
denial of emotional and phantasy life, showing often psychosomatic reactions 
during stressful periods in their lives. Even during the loading test their attitude 
was garded, defensive, they were tense and both showed great resistance to 
acknowledge and report their reaction. 
One patient (no. P 9), though admitting the very severe psychopathological 
changes (c.q. extreme depersonalization and motor inhibition) which occured 
during the loading, stated that it could not be true. A biological genesis of a 
mental illness did not fit in with her antipsychiatric oriented vision. 
A change in attitude can also alter the experience of the reaction. This is well 
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illustrated by patient P 6, who at a first loading test at the age of 18 became 
depersonalised, paranoid and inhibited after serine, but reported no dyspercep-
tions. At the time he was a childish boy, strongly emotionally attached to his 
mother, and had just started his university studies. He was very defensive 
regarding a discussion of his intrapersonal problems, which were evidently 
present. Two years later a second loading test was performed after his second 
psychotic episode. His personality had become much more mature and open, and 
he had become psychologically independent of his mother. The reaction to serine 
now gave different results (this reaction is rated in Table l). Similar circum-
stances apply to patient P 16. 
Patient P 4 reacted chiefly with euphoria and perceptual changes on serine in 
1977, but reacted with distinct changes in time sense, body image and a negative 
mood in 1979 when serious individual and psychosocial problems were prominent. 
In patients P 7, P 8, and C 2, only slight and perfunctory changes in sensory 
perception were reported. But in contrast to this the reaction as a whole was 
severe, with clear cut paranoid delusions and delusions of grandeur. Neuroleptic 
medication was considered, but finally it was decided not to interfere. No 
relation between the severeness of the natural psychotic episodes and the 
aminoacid-induced psychosis has been found, except for patient no. C 2 who has 
been hospitalized many times due to her frequent relapses. 
Of considerable interest again are subjects C 1 and C 2, who were not predicted 
to react. During their natural psychotic states the dysperceptions were so 
inconspicuous that even during the post-psychotic interview these patients were 
considered as 'negative'. However, after the loading test both patients realized 
that the same changes though very perfunctory had also been present during 
their spontanous psychotic states. 
Methionine as a methyl donor might also be able to evoke a reaction. However, 
administration of this aminoacid to serine reactive patients did not evoke 
specific symptoms. 
It is not inconceivable that administration of serine and glycine over a prolonged 
period of time, comparable with the methionine loading test in schizophrenic 
patients, can induce mental alterations in more subjects. At least, the latter 
procedure might finally result in a decrease in concentration of brain aminoacids 
and diminuation in concentration of the neurotransmitters gamma aminobutyric 
acid, dopamine, and noradrenaline (27). 
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Organic factors and loading test 
Among the 'reactive' patients there are some (P 2, P lt) with a known organic 
disease thought to be related to the disturbed serine-glycine metabolism. The 
relationship of this disturbed metabolism and porphyrin biosynthesis has been 
discussed elsewhere (1, 5), but two other patients (P 12 and P 18) need further 
explanation. 
Patient P 18 has suffered from a chronic B-viral hepatitis since 1976, which has 
been treated with Prednison 10 mg and Azathioprine 50 mg daily since 1977. 
Following this he began to suffer from depressive episodes and later on from 
characteristic attacks in which he was extremely anxious and aggressive, 
accompanied by multiple sensory perceptual distortions and colourful hallucina-
tions and finally a troubled sensorium. Although the attacks did not last more 
than 6 hours, the frequency of up to once a week caused great problems. 
Folic acid therapy (15 mg/day) was prescribed despite normal blood levels. After 
4 weeks of therapy attacks ceased. The loading tests performed were positive for 
glycine. 
Patient P 12 had experienced 4 psychotic episodes, each lasting several months, 
during which the typical sensory distortions with an unimpaired consciousness 
were reported, in addition to delirious periods suggestive of an organic disease. 
Several liver function tests (transaminases) were intermittently disturbed to-
gether with a rise in body temperature. No cause has been found up to now. 
The loading test procedure was repeated and both tests were positive for serine. 
During a later spontaneous psychotic episode, distinct epileptic discharges of 
temporal lobe origin have been found. 
It is possible that the liver disease and/or its treatment of P 12 and P 18 may 
also have affected folate metabolism. The LSD-like symptoms that have been 
reported in a case of hepatic failure is of interest in this respect (28). 
The fact that methyl tetrahydrofolate is an epileptogenic substance (29, 30) is of 
considerable importance in linking the various conditions: liver disease - special 
types of psychoses - epileptic phenomena. 
In relation to the latter phenomenon it should be pointed out that our first 
patient also suffered from an epileptic attack during a psychotic episode, as did 
patient P 2, suffering from porphyria variegata, during a second admission. 
Patient P 8 showed an electro-encephalographic discharge pattern of temporal 
lobe origin. The so-called temporal lobe features of temporal lobe epilepsy are 
indistinguishable from many of the typical symptoms of the psychosis presently 
described, which may point to a common neurophysiological substrate. In this 
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context, it is worth noting that Mitsuda reports the frequent incidence of 
epilepsy in relatives of patients suffering from 'atypical~ psychosis (31). This type 
of psychosis is probably identical with the so-called degeneration psychosis as 
diagnosed in our clinic (9). 
The erroneous predictions 
For three out of nine patients who did not show the expected response on the 
loading test, no obvious due for this failure could be found. 
One elderly patient (age 63 years) had suffered acute attacks of porphyria 
variegata with the characteristic psychotic symptomatology. The second patient 
had an anxious reaction with accompanying vegetative symptoms to all powders 
administered. The third patient reacted dearly only after glucose (see Results). 
Of the other six patients it became clear that the diagnoses had to be revised: 
into hysterical psychosis twice, into reactive psychosis, manic-depressive psy-
chosis and borderline state once; a schizophrenic process had to be diagnosed in 
one patient. 
The observation period after the negative loading tests made dear that the 
latter patient became more and more withdrawn, lived in a bizarre delusional 
world and finally inappropriate affect and affective blunting became evident. 
The remaining five patients have some characteristics in common that have led 
to the faulty prediction. These patients suffered from a subjective intensifica-
tion of light and sounds. One patient could not bear this without ear props and 
sunglasses. After the negative loading results it was realized that none of these 
patients suffered from anomalous perception of colours, nor did they complain 
about a distorted perception of shapes, distances etc. Thus a more general 
oversensitivity rather than a distorted perception was present. 
All patients also suffered from severe depersonalization. It is apparently the 
same subjective intolerance to bright light, noises etc. as encountered in the 
neurasthenic syndromes, which can also exhibit depersonalization (32). 
In addition, two out of these five patients also said that they intermittently 
suffered from a distorted perception of the faces of others or of their own 
mirrored faces. Inquiry made clear that these distortions were indeed very 
selective, as the rest of the surroundings were perceived as unchanged. It is 
conceivable that these isolated dysperceptions can be understood as being 
comparable with conversion reactions such as narrowing of the visual fields, 
micropsia, visual blurring etc. 
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Thus in retrospect it appears that two mistakes can be made. 
F1rstly, oversensitivity to light and sounds is very easily confused with the 
intensification and distortion of sounds and light as experienced by the positive 
patients. 
Secondly, the presence of selective perceptual distortion can easily lead to an 
erroneous inclusion for loading. The distorted sensory perception during the 
psychosis of the reactive patients affects in principle everything that is 
perceived. It has a more global character, including dysperception of colours. 
Control subjects 
Healthy volunteers did not show any reaction. In the control patients with 
sensory perceptual disturbances belonging to another category of psychotic 
disorders no psychopathological changes were evoked. The negative reactions in 
the schizophrenic group do not exclude that dysmethylation of monoamines may 
be a possible cause of certain types of schizophrenic illnesses. Higher doses or 
administration for a longer period of serine or glycine may lead to psycho-
pathological reactions. 
Of the control groups of acute psychotic illnesses with a benign course but not 
showing disturbances in sensory perception, two patients reacted unequivocally 
on both aminoacids. Before loading their dysperceptions obviously had escaped 
attention (see Reactive Patients). 
In the complete control group (all patients plus normals) minor reactions due to 
anxious anticipation have been observed less frequently than in the reactive 
groups. Conceivably, an inevitably more relaxed attitude of the persons ob-
serving may have contributed to this. 
CONCLUDING REMARKS 
Up to now the loading test as performed in our clinic seems a valuable device in 
constructing a homogenous group of patients out of the group of Unclassifiable 
Psychotic Disorders. 
The postulated endogenous synthesis of hallucinogenic substances as a result of a 
disturbed serine-glycine metabolism, has still to be substantiated. The charac-
teristic symptoms during the natural psychosis as well as most of the symptoms 
observed during the loading tests justify this hypothesis. 
From a retrospective study (submitted for publication) we calculated that the 
annual incidence of new admissisons of this type of psychosis would be 
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2-3 patients out of 200 psychotics in our clinic. The detection of the patients 
during their first admission to our hospital did not exceed this number. The other 
patients were already known or have been referred to us. 
During the study five patients, one of them suffering from variegate porphyria, 
refused the loading test procedures. Another patient died due to somatic 
complications. This patient suffered from acute intermittent porphyria. 
ABSTRACT 
In accordance with the transmethylation hypothesis we postulated that acute 
psychotic states showing complete recovery and characterized by a distorted 
sensory perception at the onset of the psychosis, are the result of an aberrant 
one-carbon transfer due to a disturbance in the serine-glycine metabolism. 
After recovery from the acute psychosis a single oral loading with serine and in a 
few cases with glycine or serine as well as glycine evoked characteristic 
symptoms (chiefly changes in sensory perception and mood) in 22 out of 
31 patients. Two patients in the control group reacted in an identical way. The 
symptoms started a few hours after administration of the aminoacid and lasted 
for several hours. 
The psychoses of the reactive patiehts are a sub-group of the Psychotic 
Disorders Not Elsewhere Classified of the DSM-III. The simple loading tests 
described should be of great value in creating a homogenous group of psychotic 
disorders within the poorly defined group of the Unclassifiable Psychoses, and 
open a potentially rewarding path to increase our understanding of the biological 
basis of these psychoses. 
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ADDENDUM OF 2 CASE REPORTS 
Patient P 6, male; aged 21. Report of his second psychotic episode after a two 
year episode of uncomplicated life. 
Psychosis broke out after a period of heavy physical training combined with a 
slimming diet in order to lose weight for a rowing competition. The night and the 
day following the (lost) competition were celebrated with a large quantity of 
alcoholic beverages and complete lack of sleep. Odd behaviour was observed the 
next day and (re)admlsslon in our hospital was arranged. 
Patient was anxious, had a reddened face and perspired profusely. He uttered 
short sentences, that held no relationship to each other. Nevertheless, it became 
clear that patient experienced the time as running very fast in contrast to his 
slowed train of thought. Occasionally time stood still. 
Although the patient tried to tell us about his manifold sensations, he was unable 
to verbalize the rich visual dream-like experiences most of the time. Terrifying 
scenes like drowning and hanging were present, but almost every stimulus from 
the outer world evoked abundant visual imagery. Some questions made him panic, 
for he was unable to take phrases at an abstract level, but instead visualized and 
took them literally and concretely. 
Frank hallucinations were also ?resent, he saw the first author, to whom he 
ascribed magical powers (!), coming through closed doors and conversing with 
him. 
The patient stated that he disliked the idea of being elected to be Jesus, 
however, he 'had the Cross', pointing to his crotch (the Dutch 'kruis' has both 
meanings), and simultaneously complained about pain in his left shoulder due to 
bearing the Cross. Many objects were thought to be related to the Holy Trinity 
(three billiard balls, three portions of food etc.). 
Patient had floating sensations, saw everything deformed; colours, light and 
sounds were perceived as sharp, piercing, shrill and brilliant. Objects and his own 
body expanded and shrank constantly. He did not feel the overheated water on 
his skin when showering; fortunately the nursing staff were able to prevent him 
from burning himself severely. Patient also felt that some force was stretching 
him and that he was inflated. Moreover, others could look into his skull and thus 
know his thoughts. He deferred shaving, because he could shave his thoughts 
away from his head. He refused to look into mirrors for his gaze would destroy 
him. When eating he said that he could hear as well as taste the flavour of fruits. 
Apart from a few short stuporous episodes, motor behaviour was strikingly less 
disturbed. 
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These dramatic and kaleidoscopic experiences disappeared after a few weeks 
during treatment with neuroleptics, a high calorie diet and appropriate separa-
tion. Although the perceptual disturbances were reported to be absent, the 
patient was nevertheless unable to concentrate and reacted on every stimulus. 
Short episodes of hallucinations and relative inability of abstract thinking 
remained present for a months. In this period patient often felt in a state of 
extreme blessedness, contrasting to the anxious episode at the onset of the 
psychosis. A systematic delusional system never emerged. 
Loading test (positive for serine): 
Three hours after administration of the powder it was noted that patient looked 
tense, was sweating and had a reddened face. He stated that he felt himself 
bodily slowed down and strangely empty. He reported that he was thinking very 
fast and felt more powerful, able to do anything. 
He gradually became euphoric, but two hours later he reported that he perceived 
his surroundings as 'through the frame of a picture tube'. In addition, the frame 
was somewhat overturned. The centre of his narrowed field of vision was very 
clear, the outer area very dark. The brigthness of light and colours was dulled. 
Instead of his initial euphoric mood he became more and more withdrawn and 
suspicious. He walked slowly and very carefully and stated that time had slowed 
down too. 
Eight hours after administration patient reported that he felt normal again. He 
attributed his suspicious attitude to the fact that the evoked mental and 
perceptual alterations reminded him of the onset of his natural psychosis which 
made him apprehensive and paranoid towards the investigator. 
Patient P 11, 24.-year-old female, became psychotic while on holiday, during 
which attempts to seduce her by a homosexual girlfriend mobilized old and 
repressed problems of sexual identity. Long nightly discussions without sufficient 
sleep followed till one day, at dawn, she noted that the otherwise colourful, 
brilliant landscape was completely colourless ('as if I was colour-blind'). From 
then she became more anxious and depressed, and after a few days, however, loss 
of sexual inhibition and motoric restlessness were noted. Loose verbal associa-
tions and the feeling that she possessed extraordinary powers were prominent on 
admission. In contrast to her first experience she stated that colours and sounds 
were very intense and that time was running fast. Objects and space were 
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deformed. She smelled blood and suffered from visual (fire) and auditive (words) 
hallucinations. 
The patient herself was much more preoccupied with strange bodily feelings then 
with the changed environment or hallucinations. She complained about the 
feeling of being filled-up, pains all over and the feeling of electricity flowing 
into her body. Sometimes she felt herself shrinking and was terrified by the 
delusional belief of being changed into a boy. In addition, she stated that she 
could diffuse with others, although her capacity of thought reading was more 
often uttered. 
She felt JeSus in her body, which held also some relationship to the fact that she 
thought she was able to make her sister pregnant. The condensation of the Dutch 
'je zus' (=your sister) produced the evidence. 
Although anxiety dominated, inexplicable feelings of ecstasy and unmediated 
direct apprehension of the 'essence of the universe' were sometimes present. 
Delusional ideas were restricted mostly to her problems of sexual identity, but 
even these were fleeting. Also transistory paranoid delusions and ideas of 
reference were present in addition to her tendency to attribute assessory 
supranatural transcendent meaning to every event and object. 
Recovery took place gradually, with short relapses, but nevertheless complete 
within four months. 
The spontaneous written account of her experiences after the loading day 
(positive for serine) is given here: 
'About 11 o'clock I felt dizzy and had a stomach ache. The light outside pricked 
into my eyes and seemed unusually sharp. 
I felt peaceful, but estranged from the surroundings. Objects were being 
deformed and shapes changed. Colours became very beautiful. I felt unreal and 
looked at others from a great distance. I had the sensation of being high from 
hashish. 
Gradually I felt sicker, a sort of lump in my throat, my eyes were painful through 
a sort of pressure from behind them. I lay down with a scarf over my eyes, 
because the light even with my eyes dosed was still piercing. The air pressed 
heavily upon me and felt woolly. Thinking centred upon round forms, the 
undulating floor. I felt that I grew longer, a stretching of he·ad and feet. There 
was a burning sensation, above my nose, the thought of 'a third eye' flashed 
through me. Walking was very slow or seemed to be slow, my legs felt like 
spaghetti, weak, power less. 
The shining sun through the window made me think: 'It shines for me, it shines 
95 
due to me' (I recognized this from the first period of my admission). Thanks to 
the preserved sense of reality I succeeded to put it into normal proportions'. 
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CHAPTER V 
DISCUSSION 
In the first chapter a young woman is presented whose acute psychotic episode(s) 
were characterized by multiple distortions of sensory perception, while con-
sciousness remained unimpaired. The resemblance with a LSD or mescaline drug-
induced state was str lklng. 
We postulated that endogenous production of hallucinogenic substances was 
responsible for her psychosis. 
Metabolic aspects and loading tests 
Based on literature, we conclude that such hallucinogenic substances can result 
froni an increased production of one-carbon moieties. At the oxidation level of 
formaldehyde, non-enzymatic reactions with monoamines will result in the 
production of beta-carbolines or isoquinolines, several of which are potent 
hallucinogenics. 
One-carbon metabolism is normally accurately tuned to the requirements of the 
ultimate methyldonor in almost all methylating processes: 5-adenosylmethlonine. 
When needed, the demethylation of serine, yielding glycine, is a source of de 
novo produced one-carbon units (in the form of N5 -N 10 methylene THF). 
A few metabolic pathways offer the possibility of a (temporarily) abnormal 
increased production of CH2=THF and thus the enhanced risk of splitting into 
formaldehyde. 
An increased pyrrol synthesis, as occurs in the acute porphyrias, in which an 
excess of the precursor glycine is needed, makes an increased serine to glycine 
conversion necessary. 
Abnorma11y enhanced catabolism of glycine via the cleavage enzyme and in 
particular the succinate-glycine cycle is another possibility. However, such 
disturbances in metabolism of glycine are unknown. 
Other metabolic diseases, genetic enzyme deficiences and vitamin deflciences 
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interfering with one-carbon metabolism are not likely to result in trapping of 
CH2= THF due to complex feedback regulations. 
A porphyric disease could be substantiated in 5 of our patients suffering from the 
characteristic psychotic states. One patient suffered from acute intermittent 
porphyria, and died during a porphyric attack. Another patient suffering from 
porphyria variegata refused the loading tests. Of the remaining two patients with 
porphyria variegata one reacted to the serine loading (patient P 2) and, remark-
ably, no response was observed in the other patient. 
It is noteworthy that the porphyric disease of these latter four patients was 
discovered due to the current project. In these patients neurological, abdominal 
and dermatological features were absent or had been present rather incon-
spicuously before the actual psychosis. 
Patient P 4 suffers from porphyria cutanea tarda which is related to the use of 
contraceptives and abuse of alcoholic beverages. The positive serine loading test 
in this patient offers an explanation for the psychosis observed, but complicates 
the understanding of the incompletely understood pathogenesis of porphyria 
cutanea tarda. 
From a clinical point of view, the illness of the first patient corroborates the 
tentative diagnosis of AlP. However, this could not be proved biochemically. 
In the much quoted study of Roth (see chapter I) a multiform psychosis 
accompanied by symptoms suggestive of porphyria has been described. However, 
the argument relating both conditions is refuted by the negative biochemical 
findings. A problem that is solved by Roth by introducing the term 'porphyria 
without porphynuria'. 
The relationship between florid psychoses with concomitant somatic symptoms 
and a porphyric disease may even be of historical importance. King George III's 
multiform psychotic episodes have been attributed to porphyria(!), although this 
has been challenged by authorities in the field of porphyria variegata on 
biochemical and genetic grounds (2). 
Regrettably, in the psychoses due to true or 'para' porphyria no unequivocal 
mention has been made of the typical distorted sensory perception we noted in 
our patients. 
A disturbed serine-glycine metabolism could be demonstrated indirectly in most 
of the selected patients, whether suffering from porphyria or not. Serine evoked 
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characteristic psychopathological symptoms, identical with those reported during 
the natural psychosis, a few hours after loading with a low dose (2 mmol/kg body 
wt.), which is in agreement with the notion that an increased serine to glycine 
conversion is causally related to the described psychotic states in these patients. 
In addition glycine, and both aminoacids (in a few patients) evoked characteristic 
symptoms. In these patients, this points to an elevated catabolis.m of glycine by 
the cleavage enzyme or the succinate-glycine cycle yielding one-carbon units 
too. More direct evidence for an increased serine to glycine conversion during 
the psychoses is offered by the low serine excretion in the first 4 patients, 
suggesting a high consumption. The elevated excretion of glycine of the first 
patient during psychosis is enigmatic. At least in this particular patient it is an 
argument against an increased catabolism of glycine or a reconversion of glycine 
to serine. The latter is in agreement with the findings of Richards and Scott (3), 
who demonstrated this impaired conversion in AlP patients. 
According to the report three English AlP patients, at the moment free of 
symptoms, were orally loaded with glycine (25 mg). Serine and glycine plasma 
concentration was studied by hourly plasma sampling, after which a second 
loading dose of 25 mg was administered without plasma samplings. 
No serine synthesis could be detected in these three patients. Remarkably, in the 
same study three Swedish AlP patients showed an increase in serine plasma 
concentration after loading within the same range as healthy controls. 
No reason for this difference is given, nor do the authors allude to any other 
difference than the countries of origin. 
It obviously escaped their attention, that, according to their own report, the 
Swedish patients were treated with vitamin B 12. The latter substance will 
facilitate normal methylation, or at least will discharge the methyl(ene) over-
loaded THF-cobalamine cycles and thereupon deblock the inhibition of SHMT, 
making serine synthesis after glycine feeding possible again. 
The temporarily beneficial effect of vitamin B 12 administration in our first 
patients is in agreement with this. 
Demonstrating a disturbed serine-glycine metabolism in the patients by means of 
estimations of the hourly serine and glycine plasma concentration during a 
loading test appears to be rather successful. The preliminary data suggest that 
serine steady state levels in serine positive patients are decreased without 
changes in concentration of other aminoacids. Besides glycine disappearance is 
delayed in serine reactive patients. Conversion of glycine to serine was impaired, 
while conversion of serine to glycine is enhanced (publication in preparation). 
Before any definite conclusion can be drawn more patients have to be studied. 
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We were unable to collect 24 hour urine specimens in most of the patients during 
psychosis, due to lack of compliance. 
As mentioned in Chapter I much attention has been paid to the methionine 
loadings of patients suffering from chronic schizophrenia. The intention of these 
experiments is the same as the present investigation, viz. to substantiate 
clinically a disturbed one-carbon metabolism supposed to be responsible for 
certain psychotic states. 
(In the sixties, faulty transmethylation of catecholamines or indolamines was 
postulated to occur in 'schizophrenia', while in our hypothesis the cyclization of 
monoamines (most likely indolamines) is suggested to be causally related to well-
defined acute psychotic states). 
The earlier methionine loading tests were also quite successful in inducing new 
symptoms or flare-ups of psychotic symptoms in schizophrenic patients. 
From the thorough review by Cohen (See Chapter I) it appears that at least 62 
out of 107 patients (from 10 studies) reacted in some way to loading, whether or 
not MAO inhibitors were given concomitantly. 
The nature of the reaction as an exacerbation of the already existing schizo-
phrenic process has been doubted, since many of the descriptions are clearly 
suggestive of a superimposed toxic psychotic state. 
Nevertheless, worsening of the pre-existing psychoses without organic signs has 
been reported in 32.7% of the patients studied. However, the idea that such a 
methionine loading will stimulate normal or abnormal transmethylation of 
catecholamines in man and animal has not been substantiated biochemically up 
till now (4, 5, 6, 7). 
The essence of the reaction of the methionine loadings remains enigmatic, a 
disturbance in transsulfuration or indirect disturbance of monoamine metabolism 
instead of transmethylation may be responsible. 
The limited number of methionine loading tests performed in healthy controls 
(5?) and in non-schizophrenic psychotic patients makes further speculation about 
the specificity of the reaction difficult. 
The abundant literature on the presence of abnormally methylated derivatives of 
monoamines in urine of schizophrenics does not give solid proof for the 
transmethylation hypothesis. Discussion of these often conflicting results is 
beyond the scope of our present investigation. 
It is doubtful if the 'hallucinogenic model of schizophrenia' is appropriate for all 
100 
schizophrenic psychoses. Sensory perceptual distortions are noted to occur only 
in some of the schizophrenic patients during the acute phase and nuclear 
symptoms of schizophrenia such as affective blunting, lack of insight and the 
preponderance of auditory hallucinations etc. are not found to be characteristic 
of hallucinogenic drug-induced psychotic states. 
The latter arguments may be challenged by pointing out that there is insufficient 
information about chronic (daily for months) hallucinogen abuse, and thus does 
not allow a complete refutation of the transmethylation model of schizophrenia. 
More so-called schizophrenic patients who (have) suffer(ed) from dysperceptions 
ought to be examined. 
At this moment only four residual schizophrenic patients, having suffered from 
dysperceptions, have been loaded in our series with negative result. 
The natural psychosis of the respondent patients of the present study are much 
more concordant with a hallucinogenic model of psychotic illness. The natural 
type of psychosis observed and the emergence of unambiguous characteristic 
symptoms a few hours after loading in most of the recovered patients are 
completely compatible with such a model, even when one wishes to omit those 
induced reactions without the typical sensory perceptual disturbances of light, 
colours, sounds, shapes and distances (P 9, P 15, P 20). 
The negative loading tests in other groups of psychotic illnesses stress the 
specificity of the reaction and make it a valuable instrument for defining a 
homogenous group of psychotic illnesses. 
The (reported) absence of dysperceptions during a loading day may be due to 
personality or situational factors (see Chapter 4.). Besides, the dose - 2 mmol/kg 
body wt. - may be too low to induce a full-blown reaction, but sufficient to 
provoke the early stages of the reaction (e.g. depersonalization). It can also not 
be excluded that a reaction can be restricted to vegetative symptoms and some 
feelings of apprehension or tension. Further experiments with higher and/or 
repeated doses are needed to clarify this. However, it seems more appropriate to 
use less burdening procedures (for the patient) such as the search for halluci-
nogenic substances in blood and urine. 
The loading procedure as described is rather simple and not harmful to the 
patient. Administration of serine or glycine for weeks or month!:i, similar to the 
methionine loadings, in order to evoke a reaction does not seem justified and 
possible late reactions during such a situation could be either specific or 
nonspecific toxic since the metabolic consequences of such a continuous amino-
acid overload are not known. 
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Dietary / therapeutic factors 
The literature provides evidence that catabolic states, e.g., starvation, post-
operative conditions, slimming diets with a limited protein supply, will stimulate 
the serine-glycine metabolism in order to meet the demands for de novo methyl 
group and glycine synthesis. 
The case histories of the patients show that such catabolic states are related to 
the outbreak of the psychosis, whether the patients concerned are suffering from 
porphyria or not. Moreover, there is preliminary evidence that the carbohydrate 
rich diet is also effective in patients not suffering from a porphyric disease. A 
follow-up study of several patients supports this idea, but definite conclusions 
cannot be drawn yet, as a larger number of patients will have to be studied for 
longer periods. 
The beneficial 'glucose effect' in porphyria patients due to inhibition of the ALA 
synthetase, does not necessarily explain the effect in other non-porphyric 
patients, unless abnormal activity of the succinate-glycine cycle is responsible 
for the psychotic states. This route (the Shemin cycle) converts ALA into 
succinate, thereby converting glycine into co2,NH3 and formaldehyde (!) (8). 
Inhibition of the ALA synthase will also diminish activity of this biochemical 
cycle. However, a general catabolite repression and the supply of exogenous 
labile methyl groups can be postulated to be responsible for the beneficial 
effects as well. 
Changes in the transport of precursor substances as tyrosine and tryptophan, and 
methionine, serine and glycine itself by the carbohydrate rich and fat deficient 
diet, complicate a simple understanding of the dietary influences (9, 10). 
With regard to therapeutic measures there is the problem of neuroleptics 
remaining ineffective, a clinical impression which is difficult to substantiate. 
Retrospective study and dally practice give the impression that in most patients 
the course of the disease is not or barely influenced by these drugs. It should be 
noted that such a failure in coping with psychotic symptoms has been noted and 
demonstrated in schizophrenia-like emotional (11) and schizoaffective psychoses 
(12). Nevertheless, the sedating effects of neuroleptics are useful in the 
management of these patients. The observations fit rather well the idea that in 
these psychoses the dopaminergic system is not responsible for the psychotic 
symptoms as is assumed for schizophrenic psychoses. 
The therapeutic and preventive effects of lithium in this type of psychosis also 
needs to be studied extensively. No definite conclusions can be drawn from the 
few patients who were treated with lithium. The lithium administration at least 
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did not prevent aminoacid-induced mental alterations. 
Lithium may influence methyl group metabolism, since it has been demonstrated 
that red blood cell concentration of choline and glycine is increased during 
lithium administration (13, 11+). 
The clinical effects of valproate may be of interest too, because of the reported 
inhibitory effect on the glycine cleavage enzyme (15). 
Clinical aspects 
The clinical picture the first patient showed after the operation imitated a LSD 
or mescaline induced state to such an extent that an intensive search and inquiry 
was undertaken to demonstrate a possible abuse of such substances. 
Her case history, however, lead us to postulate an endogenous synthesis of 
hallucinogenic substances. 
In the retrospective study only one patient (out of 27) was reportedly suspected 
of such a drug abuse based on the characteristic clinical picture. 
Textbook descriptions emphasize the sensory perceptual distortions and psy-
chedelic experiences of hallucinogenic use. The problems of prolonged adminis-
tration and habituation, the i11fluence of personality factors shaping the drug-
induced, altered mental state, the incorporation of perceptual anomalies in new 
conceptions and notions that can conceal the original perceptual experiences etc. 
are neglected. What holds for exogenous hallucinogenics will also hold for such 
endogenous substances. 
Thus, short-lived or even absent disturbances in sensory perception do not refute 
the hypothesis of endogenous synthesis of hallucinogenic substances in these 
patients. The positive loading tests in the two patients from the control group 
demonstrate how perfunctory experiences of altered sensory perception can 
escape the patients' attention, or how their memory may be blotted out by the 
subsequent psychotic experiences. 
The problems of the clinical presentation of dysperceptions as reported by 
patients have been well understood and investigated by orthomolecular psy-
chiatrists (16, 17). 
The Experiential World Inventory of El-Meligi and Osmond in its present or a 
revised form may be of importance to unravel patients' experiences into 
fundamental categories (18, 19). 
103 
Classification 
It was assumed that all psychotic episodes of the first patient were also caused 
by the postulated disturbance(s) in serine-glycine metabolism. 
The most impressive change in the clinical picture observed on the ward took 
place when the akinetic hallucinatory drug-like state changed into the hyper-
kinetic-paranoid amphetamine-like psychosis. 
It is tempting to speculate, regarding the effect of the addition of tryptophan to 
the diet, that a substantial depletion of the most likely substrate for abnormal 
one-carbon transfer, viz. the indolamines (20, 21) opened up the possibility for 
alternative routes of abnormal one-carbon transfer, in particular the cate-
cholamines. 
All sorts of psychotic states were observed previously: catatonic, depressive, 
hypomanic, auditive and visual hallucinosis-like episodes or mixtures of these. 
When trying to reduce all these different psychoses to one common denominator, 
the vague label of schizoaffective psychoses seems most appropriate. 
In agreement with the DSM-111 the adjective 1unclassifiable1 is completely 
justified, which in that context means that criteria for schizophrenic, paranoid, 
organic, and affective psychotic disorders are not fulfilled. The term Unclas-
sifiable (literally: Psychotic Disorders Not Elsewhere Classified) denotes the 
doubt of American psychiatry in strict adherence to the two entity principle, 
whether a separate category of psychoses apart from the classically recognized 
functional psychoses can exist. 
Such a point of view is in sharp contrast with the European (and Japanese) ideas. 
Cycloid, psYchogenic, degeneration psychosis, bouffee delirante, are regarded as 
separate psychotic entities. Despite the fact that there is considerable overlap 
between the psychogenic psychoses on one hand and the cycloid, and degenera-
tion, atypical psychoses, bouffee delirante on the other, and that in course of 
time a schizophrenic or manic-depressive illness may be recognized as the basic 
illness, the former psychoses are firmly rooted in European psychiatry. 
Long before the schizoaffective psychosis was 1discovered1, the label of degen-
eration psychosis was intended to designate exactly all those psychoses bearing 
resemblance to the functional psychoses, but showing their own clinical courses. 
They were also considered to be autochthonous (22, 23). 
At present, at least in our clinic, and in agreement with its predecessor the 
'bouffee delirante des degenerees' (!) of Magnan (22) the use of the term has 
become restricted to a characteristic type of acute psychoses, viz. psychosis in 
which the patient is overwhelmed by visionary, cosmic and ecstatic experiences, 
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delusional ideas, abundant hallucinations, ideas of grandeur, prophetic-ecstatic 
states, sudden insights, motor disturbances and strong lability of affects, with a 
tendency to show a complicated, polymorphous and alternating picture (25). 
(When euphoric mood accompanied by verbal and motor desinhibition dominate 
the clinical picture, the term atypical mania instead of degeneration psychosis is 
also used.) 
These atypical manias/degeneration psychoses do differ from the reactive/ 
psychogenic psychoses from a descriptive point of view. The cycloid and atypical 
psychoses have more in common with the degeneration than with the psychogenic 
psychoses. 
The retrospective study, solely based on the presence of dysperceptions, un-
expectedly supported this twofold division regarding 'schizoaffective and related 
psychotic states' commonly made in our clinic. 
The disturbances ln sensory perception were found to be mostly associated with 
the diagnosis degeneration psychosis, whereas a lack of distorted sensory 
perception together with the presence of distinct depersonalization was noted in 
the psychogenic psychoses. 
In some of the descriptions in case histories of cycloid, schizoaffective, and 
degeneration psychoses, dysp~rceptlons are mentioned by their authors. In other 
' 
words the model psychose~ of LSD, mescaline, psilocybin do indeed exist in 
nature, however paradoxically this may sound. 
In my opinion the overlooking or underestimation of this possibility must be due 
to the mostly very short-lived, and/or perfunctory experience of the dyspercep-
tions. It was the longlasting presence of these disturbances in the first patient 
that made us aware of and evoked our interest in the possibility of endogenous 
synthesis of hallucinogenic substances. 
From the present studies it is evident that short-lasting dysperceptions do not 
exclude such a synthesis. 
From the failure to induce mental changes by aminoacid loadings in some 
patients it has become dear that when dysperceptions are present they have to 
be characterized by a global character, including changes of colour perception 
and of perception of the whole spatial world. 
The experience of intensification of light and sounds, disturbed time sense, 
changes in body image and of distorted perception of single items are not 
pathognomonic by themselves, and have no predictive value with respect to a 
positive reaction after a serine or glycine loading. 
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Some types of psychoses also exhibit global dysperceptions and give difficult 
differential diagnostic problems. 
Temporal lobe epilepsy, borderline states, acute schizophrenic psychoses have to 
be excluded. EEG and follow-up studies are necessary to disentangle these 
problems. And in general all organic processes which may interfere with the 
neurophysiological systems involved in perception, must be reviewed on negative 
loading tests. After positive loading tests, porphyria must be excluded. 
The exact nature of the aberrant serine-glycine metabolism in the remaining 
patients will have to be established. However, for the time being, the relatively 
simple loading test offers the possibility of distinguishing one type of psychosis 
from the largt group of acute psychotic illnesses. The test also shows that this 
type of psychosis can be recognized most of the time without great difficulty by 
the presence of character is tic global dysperceptions. 
These phenomenological and biochemically-induced characterizations enable us 
to reclassify the 'Psychotic Disorders Not Elsewhere Classified'. It appears that 
former claims from European and Japanese psychiatry regarding classification of 
acute psychotic states with complete recovery but a tendency to run an episodic 
course, cannot be simply ignored by assuming that they are all and the same, 
merely schizoaffective. 
The present studies emphasize that typological descriptions of the degeneration 
or atypical psychoses versus reactive/psychogenic psychoses are of considerable 
importance for nosological purposes. However, the simple classification offered 
here on basis of a few pathognomonic clinical characteristics and a biochemical-
ly inducable reaction will be of value in attempts to prove that a third functional 
psychosis does exist. 
Further biochemical studies to unravel the nature of the disturbed serine-glycine 
metabolism, and to demonstrate the synthesis of a hallucinogenic substance 
caused by it, are in progress. 
Follow-up and family studies and the ongoing studies of the effect of dietary 
measures are necessary to confirm the entity of the episodic polymorphous 
psychoses (26). 
Moreover these studies should result in improved treatment and prevention of 
these psychotic states. 
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SUMMARY 
This thesis comprises an investigation into the clinical-phenomenological aspects 
and the experimental-biochemical determination of a subtype of acute psy-
choses. Psychoses which ln general show complete recovery, mostly have an 
episodic course and belong to the large group of acute psychotic syndromes 
which cannot be classified either as manic-depressive, schizophrenic, paranoic, 
or as organic. 
In chapter I there is the case history of a patient suffering from acute psychotic 
eposldes. After an operation she showed a psychosis identical with a LSD- or 
mescaline-induced state. Acute intermittent porphyria might be the cause of the 
psychosis. A high carbohydrate diet resulted in complete recovery. 
It was assumed that as a result of increased porphyrin production, hallucinogenic 
substances are synthesised. 
The enlarged porphyrine synthesis makes an increased conversion of serine into 
glycine - one of the precursor substances of porphyrins - necessary. Methyl 
tetrahydrofolate being disengaged in the process of serine into glycine con-
version will accumulate, augmenting the chance of segregation of formaldehyde. 
A non-enzymatic reaction of formaldehyde with monoamines will result in the 
production of psychotogenic substances of the beta-carboline and isoquinoline 
type. 
An investigation into the literature on the incidence of such psychotic syndromes 
in porphyria and also in metabolic diseases and vitamin deficiencies, often 
supposed to create an accumulation of active carbon moieties such as 
methylene- and methyl-tetrahydrofolate, turns out to be negative. 
The biochemical literature appears also to offer few cues to postulate that 
vitamin s 12 deficiency and homocystinurias a.o. will cause a considerable 
accumulation of methylated folates. Only a forced catabolism of serine and 
glycine, in porphyria or otherwise, seems to make this possible as things stand 
now. 
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In chapter II four patients are described in short. All were suspected of suffering 
from porphyria and had been suffering from psychoses in which sensory distur-
bances of light, colour, sound, shape, space, and time were mentioned. 
In two Patients porphyria could be diagnosed, though a high carbohydrate, low fat 
and low protein diet resulted in quick recovery in all patients. 
Based on the central thought that an accelerated conversion of serine into 
glycine should be the cause in all patients, oral loadings of serine, glycine, and 
glucose in restricted quantities (2 mmol/kg bodyweight) were attempted. The 
investigation was carried out double blind. 
Some hours after administration, all patients reacted to serine with distinctive 
phenomena; the first patient was also reactive to glycine. 
In particular depersonalisation, changes of mood and characteristic perceptual 
disturbances were induced. 
It is concluded that a disturbance in serine and glycine metabolism is the cause 
of the psychoses. 
In chapter III it becomes clear by means of a retrospective investigation of 71 
case histories that acute psychoses characterized by dysperceptions have been 
regularly observed (n = 27). It appears that these perceptual anomalies are 
mainly mentioned at the onset of a psychosis. 
It also appears that this type of psychosis generally shows a kaleidoscopic, 
polymorphic picture. 
They are, on the strength of their clinical description, so-called 'degeneration 
psychoses'. They are clearly distinct from a second group of acute psychosis 
without dysperceptions: mostly diagnosed as psychogenic psychoses, in which the 
clinical picture is determined by strong depersonalisation (n = 35). 
This approach offers a completely new classification of the so-called Unclas-
sifiable Psychoses of the DSM III. 
In chapter IV the results of the loading tests with serine, glycine, glucose and 
occasionally with alanine and methionine are discussed. 
Out of a total number of 31 patients who were expected to react on account of 
their clinical picture - which should be characterized by dysperceptions -
22 patients turned out to show the expected response to serine, glycine or both 
amino acids. 
Of six patients an erroneous diagnosis (schizophrenia a.o.) and/or confusion 
regarding the character of the dysperceptions appears to be the cause of the 
wrong predictions. 
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From the controlgroup (33 patients having suffered from other psychoses and 15 
healthy subjects), 2 patients also turned out to react to serine and glycine. The 
dysperceptions of these two patients had been of such a short duration that they 
were not reported. 
Conclusion: The reactions to serine and glycine appear to be highly specific for 
the described group of psychoses and support the hypothesis that endogenous 
synthesis of hallucinogenic substances may be the cause of these psychoses. 
In chapter V the various results are integrated. The idea, already put forward at 
the beginning of this century, that the degeneration psychoses form the third 
group of the so-called functional psychoses, will get a renewed and biologically 
founded base by the improved clinical and new experimental diagnostics as 
described in this thesis. 
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SAMENVATTING 
Dlt proefschrift beschrljft een onderzoek naar de klinisch-fenomenologische 
aspecten en de experimenteel-biochemische determinatie van een subgroep van 
acute psychosen. Psychosen die in het algemeen restloos herstellen, veelal 
eplsodlsch verlopen en behoren tot de grate groep van acute psychotlsche 
syndromen die noch als manisch-depressief, schlzofreen, paranoid of als orga-
nisch kunnen worden geclassificeerd. 
In het eerste hoofdstuk wordt een patiente beschreven, lijdende aan acuut 
optredende psychotlsche eplsoden. Na een operatie vertoonde zlj een psychose, 
identiek met een LSD of mescaline geinduceerde toestand. Een acute intermitte-
rende porfyrie zou mogelijk de oorzaak van deze psychose kunnen zijn. Een 
koolhydraatrijk dieet bracht volledig herstel. 
' 
.Hierbij werd verondersteld1 dat, als gevolg van de verhoogde porfyrine-aanmaak, 
hallucinogene stoffen worden gesynthetiseerd. De toegenomen porfyrlnesynthese 
maakt namelijk een verhoogde omzetting van serine in glycine - een der 
precursor-substanties voor porfyrines - noodzakelijk. Het bij de serine-glycine-
omzetting tegelijkertijd ontstane methyleen-tetrahydrofolaat zal zich ophopen, 
waardoor de kans op afsplitsing van formaldehyde toeneemt. Een non-enzyma-
tische reactle van formaldehyde met monoaminen resulteert in de produktie van 
psychotogene stoffen zeals beta-carbolinen en lsoquinolinen. 
Een literatuuronderzoek naar het v66rkomen van dergelijke psychotische syndro-
men bij porfyrle alsmede bij stofwisselingsziekten en vitamine-deficH~ntles, 
waarvan veelal verondersteld wordt dat zij ophoping van actleve koolstof-
eenheden (onder andere methyleen- en methyl-tetrahydrofolaat) zullen geven, 
viel negatief ult. 
Eveneens blijkt dat de biochemlsche literatuur welnig aanknopingspunten biedt 
door te veronderstellen dat onder andere vitamine B12-deficlentie en homo-
cystinurieen een aanzienlijke ophoping van gemethyl(een)eerde folaten zullen 
veroorzaken. Aileen een geforceerd catabolisme van serine en glycine, al dan 
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niet g.ekoppeld aan porfyrie, lijkt dit vooralsnog mogelijk te maken. 
In het tweede hoofdstuk worden in het kort vier patienten beschreven. Allen 
werden verdacht te lijden aan porfyrie en hadden aan psychosen geleden, waarbij 
waarnemingsstoornissen van licht, kleur, geluid, vorm, ruimte en tijd werden 
vermeld. Bij twee patienten kon een porfyrie worden vastgesteld, hoewel bij 
allen een koolhydraatrijk, vetarm, eiwit-beperkt dieet resulteerde in een snel 
herstel. 
Vanuit de centrale gedachte dat een versnelde omzetting van serine in glycine bij 
alle patienten de oorzaak zou moeten zijn van de psychose, werd overgegaan tot 
orale toediening van serine, glycine of glucose in een beperkte hoeveelheid 
(2 mmol/kg lichaamsgewicht). Het onderzoek werd dubbelblind uitgevoerd. Alle 
patienten reageerden, enkele uren na inname, met kenmerkende verschijnselen 
op serine; de eerste patiente bovendien ook nog op glycine. Met name werden 
depersonalisatie, stemmingsveranderingen en karakteristieke waarnemings-
stoornissen geinduceerd. 
Conc1usie: een stoornis in het serine- en glycine-metabolisme is waarschijnlljk de 
oorzaak van de psychosen. 
In hoofdstuk III wordt door middel van een retrospectief onderzoek van 71 
ziektegeschiedenissen duidelljk, dat acute psychosen, gekenmerkt door "dysper-
cepties", regelmatig geobserveerd zijn (n = 27). Het blijkt dat deze waarnemings-
anomalieen vooral aan het begin van een psychose worden vermeld. Ook komt 
naar voren dat dit type psychose in het algemeen een kaleidoscopisch, polymorf 
beeld vertoont. Op basis van hun klinische descriptle zijn het zogenaamde 
11 degeneratiepsychosen 11• Zij onderscheiden zich duidelijk van een tweede groep 
van acute psychosen zonder dyspercepties: meestal gedlagnostiseerd als psycho-
gene psychosen, waarbij sterke depersonalisatie het klinische beeld bepaalt 
(n = 35). Deze benadering biedt een geheel nieuwe c1assiflcatie van de zogenaam-
de Onclassificeerbare Psychosen van de DSM-III. 
In hoofdstuk IV worden de resultaten van de loading tests met serine, glycine, 
glucose en in enkele gevallen met alanine of methionine besproken. 
Van het totaal van 31 patienten die verwacht werden te reageren naar aanleiding 
van hun klinisch beeld - dat gekenmerkt moest zljn door dyspercepties - bleken 
22 patienten de verwachte respons te vertonen op serine, glycine of beide 
aminozuren. 
Bij 6 patienten blijkt een foutieve diagnose (onder andere schizofrenie) en/of 
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verwarring omtrent de aard van de dyspercepties de oorzaak te zijn van de 
onjuiste predictie. 
Uit de controlegroep (33 patienten die aan andere psychosen hebben geleden en 
15 gezonde proefpersonen) blijken 2 patienten te reageren op serine en glycine. 
Bij deze twee patienten waren de dyspercepties van zulk een korte duur geweest 
dat ze niet waren vermeld. 
Conclusie: de reacties op serine en glycine blijken in hoge mate specifiek te zijn 
voor de beschreven groep psychosen en ondersteunen de hypothese dat endogene 
vorming van hallucinogene stoffen de oorzaak van deze psychosen kan zijn. 
In hoofdstuk V worden de verschillende bevindingen geintegreerd. Het reeds aan 
het begin van deze eeuw geponeerde idee dat de degeneratiepsychosen de derde 
groep van de zogenaamde functionele psychosen vormen, krijgt door de in dit 
proefschrift beschreven verbeterde klinische en de nieuwe experimentele 
diagnostiek een hernieuwde en biologisch gefundeerde basis. 
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SCHIZOPHRENIA AND TRANSMETHYLATION 
The resemblance between drug-induced hallucinations and schizophrenia has 
been the inspiration for many scientists in the search for endogenous toxic 
products responsible for psychotic symptoms in these patients. The isolation 
of potent hallucinogens from South American snuffs and the identification of 
these substances as derivatives of tryptamine, such as N,N-
dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine (Holmstedt and 
Lindren, 1967), revived interest in the possibility that methylation of trypta-
mine or 5-hydroxytryptamine (5-HT-serotonin) respectively, (compounds 
formed in vivo from the amino acid L-tryptophan) represents a biochemical 
pathway involved in evoking psychotic symptoms. 5-Methoxytryptamine has 
been detected in rat brain tissue and at particularly high concentrations in the 
hypothalamus (Green eta!., 1973). It has been suggested that this compound 
might act as a precursor of the potent hallucinogen, 5-methoxy-N ,N-
dimethyltryptamine (Snyder et at., 1974). 
The formation of hallucinogenic substances from monoamines in vivo by a 
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faulty transmethylation reaction was postulated by Harley-Mason in 1952 (see 
Osmond and Smythies, 1952). However, until now no evidence has been 
provided for the formation of such methylated monoamines during psychosis. 
Although dimethyoxyphenylethylamine has been isolated from the urine of 
acute schizophrenic patients (Friedhoff and Van Winkle, 1962), a finding 
which has been confirmed by others, this compound has also been isolated 
from urine of individuals without psychiatric disorders (Watt et al., 1969). 
The formation of methylated monoamines in psychotic patients is still a 
controversial issue, but the enzymes responsible for the formation of these 
substances have been reported to be present (see Rosengarten and Friedhoff, 
1976). In 1961, Axelrod described an enzyme in rabbit lung which converts 
5-HT and tryptamine into N ,N-dimethylserotonin and N ,N-
dimenthyltryptamine, respectively. This enzyme also N-methylates pheny-
lethylamines. This methyltransferase has also been detected in brain tissue 
(Saavedra and Axelrod, 1972; Saavedra et al., 1973). Furthermore, the 
presence of a specific indok(ethyl)-amine N-methyltransferase has been 
reported in chick brain (Morgan and Mandell, 1969). Subsequently, This 
enzyme was also shown to be present in the brains of sheep and man (Mandell 
and Morgan, 1971). 
These methyltransferases use S-adenosylmethionine (SAM) as a methyldo-
nor. The report that an N-methyltransferase may convert dopamine into 
epinine, using NS-methyltetrahydrofolic acid (N5-methyl-FH4) as a methyl-
donor (Laduron, 1972), renewed the search for transmethylations in which 
NS-methyl-FH4 would act as a more specific methyl donor. Banerjee and 
Snyder (1973) reported the presence in rat brain of a methyl transferase which 
not only N-methylates tryptamine derivatives as well as phenylethylamines, 
but which also methylates 5-HT to 5-methoxytryptamine using N5-methyl-
FH4 as a substrate. However, Lin and Narasimhachari (1974) were not able to 
confirm this finding. 
Soon afterwards it became clear that N,N-dimethyltryptamine was not the 
product formed from N-methyltryptamine and N5-methyl-FH4, but rather 
2,3,4,9-tetrahydro-2-methyl-1H-pyrido (3,4b) indole, a tetrahydro-j'J-
carboline, probably by oxidative cyclization (Mandel et al., 1974). This 
reaction, however, did not occur when SAM was used as a methyl donor, 
suggesting the N5-methyl-FH4 might act as a more specific methyl donor. 
Subsequently, it was shown that epinine is not formed after incubation of 
dopamine and N5-methyl-FH4, but rather a tetrahydroisoquinoline (Meller et 
al., 1975). 
With regard to the formation of these newly discovered products, evidence 
has been presented that N5-methyl-FH4 is converted to N5-methylene-FH4 
which is further degraded to formaldehyde. The latter product is responsible 
for the formation of isoquinolines or tetrahydro-tJ-carbolines from catechola-
mines or indoleamines, respectively (Meller et al., 1975; Pearson and Turner, 
1975). 
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A survey of the biochemical pathways involved in transmethylation is 
presented in Fig. 1. All the biochemical reactions in this figure occur in the 
liver as well as in the brain (see Gaitonde, 1970). As can be seen from Fig. 1, 
the initial step in one-carbon transfer is the conversion of serine to glycine 
which may exert a key function m the synthesis of N5-methyl-FH4, 
glycine senne 
methyl 8 12 
s- odenosylmethionine _7 __ --=---' ~=---4--S-odenosylhomo-( \ cyste1ne 
taurine-....:----- cysteine_,,_ _______ Cystathionine 
Fig. 1. Pathways involved in the biosynthesis of 
methylfolates and S-adenosylmethionine 
NS,NlD-methylene-FH4 and of SAM. The first product formed in the conver-
sion of serine to glycine is NS,N 10-methylene-FH4 . This product is subse-
quently converted into N5-methyl-FH4 by methylenetetrahydrofolate reduc-
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tase, an enzyme which is inhibited by SAM. S-Adenosylhomocysteine 
counteracts the inhibition of the reductase by SAM (Kutzbach and Stokstad, 
1967, 1971). 
Clinical evidence that the tetrahydrofolic acid cycle is involved in schi-
zophrenia, or in psychosis in general, is not available (see Bruinvels, 1975). 
However, one patient has been described with homocystinuria and symptoms 
of schizophrenia (Freeman eta/., 1972; Mudd eta/., 1972) in which NS,NlD-
methylene tetrahydrofolate reductase activity was found to be impaired. It 
has also been reported that treatment of some epileptic patients with 
anticonvulsants, such as phenylhydantoin, may provoke symptoms which 
resemble schizophrenia. Reyonds et al. (1966) suggested that lowering of the 
folate level by anticonvulsant drugs might be responsible for the schizophre-
nia-like symptoms. Based on this suggestion, a hypothesis was put forward by 
Levi and Waxman (1975) relating methionine and folate metabolism to the 
pathogenesis of schizophrenia (see also Noris and Pratt, 1974). 
SCHIZOAFFECTIVE PSYCHOSIS AND TRANSMETHYLATION 
About two years ago a female patient was admitted to our psychiatric 
department who exhibited a clinical picture resembling a drug-induced 
psychosis. However, drug abuse could be excluded. The most distinct 
features of this patient were impressive perceptual disturbances, including 
perceptual distortions of the surroundings, brightness of light and colors, and 
changes in passing time. These characteristic features are also known to occur 
during fhe acute phase of schizophrenia. However, the course of the disease 
in this patient, e.g. its episodic character, with complete recovery-leaving no 
residual symptoms-after each psychotic period, the lack of thought disorder 
and a normal emotional responsiveness (even during a severe psychotic 
attack) excluded a schizophrenic process. In addition, treatment with 
neuroleptics was unsuccessful. When it was realized that during periods 
preceding the psychotic ailment depressive and/or manic symptoms had 
dominated the clinical picture, it was concluded that classification under the 
category of schizoaffective disorders would be more appropriate, at least 
from a diagnostic point of view. 
After some months, this patient developed neurological complications 
which were suggestive of porphyria. At this point a neurologist decided to 
treat the patient with vitamin B12 , despite a normal plasma concentration of 
this vitamin. During the following week the neurological symptoms as well as 
the hallucinations disappeared. However, one of the nurses accidently gave 
the patient a sleeping pill containing, among other substances, a barbiturate 
which again induced porphyric symptoms and psychotic reactions, including 
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cataleptic episodes. These cataleptic episodes lasted from minutes to hours. 
Still under the convinction that the patient suffered from porphyric disease, 
high doses of glucose were administered, a therapy based on the inhibition by 
glucose of o-aminolevulinate (ALA)-synthetase, the rate-limiting enzyme of 
porphyrin biosynthesis (Weiland, 1964; Stein and Tschudy, 1970). Although 
no abnormal excretion of porphyrins could be detected, the patient recovered 
in two days. A diet rich in carbohydrates, low in protein and fat prevented 
further serious relapses. Breaking of this diet, when the patient ate herring or 
chips with mayonnaise, once again induced psychotic reactions with a 5--6 h 
delay. The psychotic period lasted only a few hours, unless further feeding 
was refused. 
Hypothesis relating transmethylation and porphyrin biosynthesis 
Based on the findings in this patient, a hypothesis relating psychosis and 
porphyrin biosynthesis was worked out. This hypothesis is presented in Fig. 2 
and is in fact composed of two biological systems, one being the system 
involved in one-carbon transfer (Fig. 1) and the second system representing 
5-Ad-homocys S-Ad-methionine 
homocys 
1 r 
--7--,-~'\~-•• methionine 
CH3-B12 B12 
,---,:,.--""'--- CHrF H4 
cycllzotlon <j>-(CH2i2 NH2 ~ 
. ' 
' ' 
....__ - ::::---:::.. - -
FH4 7 \ ' CH2 = FH4 
ser gly 
+ 
___ _. 6-ALA 
succinyl CoA .j. 
PBG 
hie 
Fig. 2. Hypothesis relating porphyrin biosynthesis and transmethylation. 
Ad = adenosyl; PBG = porphobilinogen 
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porphyrin biosynthesis. Both systems are coupled by the serine-glycine 
conversion. In this latter system, a one-carbon unit of serine is transferred to 
tetrahydrofolic acid (FH4) resulting in the formation of glycine, one of the 
substrates for the biosynthesis of porphyrin, and N5,N10-methylene-FH4 . 
During porphyria, more glycine needs to be made available and therefore, 
the conversion of serine to glycine will be increased under these circum-
stances. Since serine-glycine conversion is the main pathway for the synthesis 
of glycine, one would expect that an increased formation of glycine will be 
accompanied by an enhanced formation of N5,N1D-methylene-FH4 and its 
reaction products. Therefore, it is not inconceivable that, under these 
circumstances, methylene-FH4 will accumulate and, as discussed above, may 
be split to form formaldehyde which will react with monoamines to yield 
isoquinolines or tJ-carbolines. The mechanism by which the increased glycine 
formation in porphyria is initiated is unknown. 
Clinical characterization 
To detect other patients suffering from the syndrome described, we scruti-
nized all patients who might belong to the group of schizoaffective psychotics. 
Table I shows the most common descriptive diagnoses which belong, accord-
Table I. Descriptive diagnoses belonging to the 
category of schizoaffective psychosis in which 
perceptual disturbances may occur 
schizoaffective psychosis 
atypical mania 
degeneration psychosis 
schizophreniform psychosis 
motility psychosis 
mixed psychosis 
cycloid psychosis 
reactive psychosis 
remittent psychosis 
episodic psychosis 
oneirophrenia 
psychogenic psychosis 
atypical psychosis 
ing to some authors, to the broad category of schizoaffective psychosis. By far 
the most important consideration was, however, that the patients we were 
looking for would be suffering or have suffered from more or less circums-
cribed dysperceptions. These dysperceptions are not included in the descrip-
tion of schizoaffective psychosis in either the 'International Classification of 
Diseases' or 'Research Diagnostic Criteria' (Spitzer et al., 1975). It was 
argued that the experience of dysperceptions could have been obscured or 
have become less important for patients overwhelmed by other symptoms 
such as anxiety, paranoid ideation, or hallucinations. It might also be possible 
that the influence of cognitive factors and interpretation based on personal 
factors would result in subjective statements by the patient in which the 
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perceptual anomaly is hardly detectable. For instance the conviction of one 
patient that he was an immortal saint was due to the perception of a small, 
white separate room as colorful and greatly enlarged, during a period in 
which a euphoric mood and a profoundly changed experience of passing time 
dominated. 
To detect dysperceptions in patients, a questionnaire developed by El-
Meligi and Osmond-the Experiential World Inventory (EWI)-was used. 
The EWI consists of 2 x 200 statements which the patient has to answer as 
true or false. The statements belong to one of eight categories. Categories 1-4 
are more directly related to perception and experience, while categories 5-8 
may be considered as related to mental processes of anomalous perception. 
The detection of changes in passing time was performed with the aid of an 
electronic metronome. The patient was asked to adjust the metronome to a 
frequency representing his personal assessment of passing time. 
Biochemical characterization 
All patients were screened for abnormal porphyrin biosynthesis and for 
homocystinuria. Some of the patients were found to suffer from porphyria, 
while none of the patients suffered from homocysteinuria. The seriousness of 
the psychosis was scored as presented in Table II. Scores 1-6 also represent 
Table II. Behavioral scores 
related to the severity of 
psychosis 
1. Anxiety 
2. Dysphoria/euphoria 
3. Depersonalization 
4. Dysperceptions 
5. Hallucinations 
6. Catatonia 
the sequence in the development of the psychosis. Because of the importance 
in methyl transfer and in porphyria of the serine-glycine conversion, via 
serine hydroxymethyltransferase, the excretion of these amino acids in the 
urine during different psychotic states was measured. Table III shows the 
excretion of serine, glycine, alanine, and tyrosine in 24-hour urine in relation 
to the psychotic state of the patients. Alanine represents another non-
essential amino acid, while tyrosine can be regarded as a semi-essential amino 
acid, since it is derived from phenylalanine, an essential amino acid and also 
depends on the food intake. Table III contains the results of the first four 
patients suffering from dysperception or hallucinations. From this table it is 
clear that serine excretion decreased during psychosis. From these four 
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Table III. Excretion of serine, glycine, alanine, and tyrosine (as percentage of control) 
in relation to psychosis 
Behavioral Serine Glycine Alanine Tyrosine 
score 
controls(3) 0 100 ± 23 100 ± 14 100 ± 39 100 ± 12 
patients( 4) 0 101 ± 26 85 ± 30 56 ± 20 82 ± 28 
G.B. 3xt 2 74 ± 2 66 ± 3 73 ± 1 98 ± 10 
G.B. 2X 4 49;54 46;36 53;43 70;78 
E.M. 3X 5 2 ± 2 201 ± 48 78 ± 26 84 ± 24 
D.S' !X 5 11 3 11 32 
A.H' lx 6 39 35 18 15 
Numbers in brackets indicate number of patients or controls. 
* D.S. suffered from porphyria cutanea tarda; A.H. suffered from porphyria variegata 
t the number of determinations on different days for the patient under the same psychotic 
conditions 
patients, two were shown to suffer from porphyria (D.S. and A.H.). Glycine 
excretion also seemed to be decreased, although one patient (E.M.) showed 
an increased excretion of this amino acid during severe psychosis. The other 
two amino acids exhibited similar excretion patterns to those in controls, but 
the two patients suffering from porphyria showed a decreased excretion of 
amino acids. Nevertheless, from this experiment it seems that a common 
factor among these four patients may be an impaired excretion of serine 
during psychosis. Such a defect might point to an enhanced utilization of 
serine by the patients, which would be in agreement with the proposed 
hypothesis. 
To obtain more direct information, it was decided to load the patients with 
low doses of serine or glycine (2 mmole kg- I) and to observe their behavior. 
Patients and healthy controls were fed a carbohydrate-rich diet for at least 
four days before loading experiments were started. Blood samples were 
subsequently taken every hour over a period of 6 h after loading was 
initiated, for determination of serine and glycine. 
As can be seen from Table IV, all patients loaded with serine or glycine 
necame psychotic to an extent varying from depersonalization to hallucina-
tions. It is worth mentioning that the evoked psychotic symptoms, according 
to the patients, were identical to their 'natural' psychotic symptoms. 
Moreover, all patients seemed to respond favorably to the carbohydrate-rich 
diet and this response was not restricted to those who suffered from a proven 
porphyria. Some patients reacted with vegetative responses to glycine load-
ing, which might be expected in porphyric patients. However, no explanation 
can be given at present for the fact that four out of five non-porphyric patients 
also reacted with vegetative symptoms in addition to the glycine-induced 
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Table IV. Schizoaffective disorders provoked by loading the patients with serine or 
glycine and their relation to porphyria, carbohydrate-rich diet and psychotic symptoms 
Patient Diagnosis Por- Response Behavioral score after 
phyria to diet loading with 
Serine Glycine 
E.M. Oneirophrenia +++ 3 4 (V) 
G.B. Schizophreniform psychosis + 4 0 
D.S. Dysphoric-
depersonalization syndrome + ++ 4 0 (V) 
A.H. Acute hallucinosis + +++ 5 0 (V) 
R.M. Atypical psychosis ++ 0 4 (V) 
I.v.d.T. Atypical mania + 0 5 (V)' 
H.V. Atypical mania ++ 0 5 (V) 
A.v.D. Psychogenic psychosis ? 4 4 
P.W. Degeneration psychosis + ++ n.l. n.l. 
A:d.H. Remittent schizophrenia + +++ n.l. n.l. 
n.l. =not loaded;.(V) =vegetative symptoms;"'= clsed eyes imagery response to diet:+++= 
total recovery, + + = decrease in frequency of attacks and improvement with at least two scores, 
+ = decrease in frequency of attacks 
Behavioral score (see Table II) 
psychosis. Although induction of psychotic symptoms, after loading the 
patients with glycine, does not, at first glance, seem to fit the hypothesis 
proposed, it is known that glycine can be converted into C02 and NH3 by the 
glycine cleavage enzyme which simultaneously methylates FH4 resulting in 
the formation of N5 ,NIO.methylene-FH4. This latter product can act as a 
substrate for cyclization of monoamines as discussed previously. Several 
interesting conclusions can be drawn from the data shown in Table IV. 
Firstly, it seems that the ability of ordinary non-essential amino acids, such as 
serine and glycine, to induce psychotic symptoms within about 5 h while 
having no effect in healthy controls, is without precedent in the literature. 
Secondly, the ability of a carbohydrate-rich diet (or glucose) to prevent 
psychotic attacks suggests that a peripheral rather than a central mechanism is 
involved in the pathogenesis of the described psychosis. 
Analysis of the plasma samples drawn from the patients before and after 
loading with serine or glycine might be expected to reflect the activity of 
serine hydroxymethyltransferase. As can be seen in Fig. 3a, a linear rela-
tionship exists between the plasma levels of serine and glycine after loading 
with serine. However, in patient E.M., glycine formation reached a plateau at 
a plasma serine concentration of about 0.3 mM. Fig. 3b shows the rela-
tionship between the plasma levels of both amino acids after glycine loading. 
In controls, as well as most of the patients, a plateau in the increased 
formation of serine was seen after glycine loading, with the exception of 
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patients A.H. and E.M. In the first of these exceptional cases, no increase in 
plasma serine concentration was detectable and in the second case, the 
plasma concentration of serine did not achieve its plateau level (0.25 mM). A 
firm conclusion concerning the activity of serine hydroxymethyltransferase in 
relation to psychosis, however, is not permissible on the basis of these data, 
since serine and glycine are also involved in other biochemical reactions, as 
shown in Fig. 4. The slopes of the curves, indicating the increase in serine or 
cysteine protein 
alanine I glyoxal ate r porphyrins ~ ~ / 
K - I 
SERINE GLYCINE C02 + NH3 
Ki K2 / j / 1 ~ protein gluthathione creatine 
pyruvate purines 
Fig. 4. Pathways in which serine and glycine act as precursors 
glycine in plasma after loading the patients with glycine or serine, respective-
ly, are presented in Table V. The limited data presented here do not permit 
firm conclusions to be drawn. Nevertheless, we have attempted to relate our 
findings to the proposed hypothesis and to account for any points of conflict, 
as outlined below. 
Table V. Slopes of the curves shown in Figs. 3a and 3b as a measure of 
the increase in plasma glycine and serine after loading patients with 
serine or glycine (2 mmole kg- I) respectively 
Controls (3) 
D.S. 
A.H. 
E.M. 
P.W. 
I.v.d.T. 
A.v.D. 
Glycine 
0.084 ± 0.012 
0.179 ± 0.012 
0.036 ± 0.033 
0.141 ± 0.020 
0.172 ± 0.008 
0.176 ± 0.002 
0.218 ± 0.019 
Loading 
Serine 
0.200 ± 0.025 
0.277 ± 0.028 
0.136 ± 0.023 
0.683 ± 0.031 
n.d. 
n.d. 
n.d. 
n.d.: plasma glycine after serine loading has not yet been determined 
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Possible interpretation of biochemical data 
The increase in the production of serine, after glycine loading, in four out of 
six patients (Fig. 3a and Table V) might be explained in two ways: 
(1) An impaired metabolism of serine. 
(2) An increased conversion of glycine into serine as the result of activated 
serine hydroxymethyltransferase. 
Since the reaction catalyzed by serine hydroxymethyltransferase is an equilib-
rium reaction, both mechanisms could account for the increased level of 
glycine. However, explanation (1) seems less probable because the excretion 
of serine, as shown in a limited number of patients, was decreased and not 
increased during psychosis (Table I). In addition, normal or low plasma levels 
of serine were found in these patients (Fig. 3a). The second explanation 
would appear to fit the results better. Any activation of serine hydroxy-
methyltransferase would, as discussed above, result in an activation of both 
conversions: serine into glycine and glycine into serine. However, the 
serine-glycine conversion, as shown in Fig. 3b, seems to have been increased 
by only 40% in patient D.S. while the glycine-serine conversion was 
increased by 100%. This difference may have been caused by porphyria, since 
the available glycine might then be used for the biosynthesis of porphyrins. 
This also holds for patient A. H. who, in fact, exhibited no increase in plasma 
serine at all after glycine loading, while the serine-glycine conversion seems 
to have been within the normal range for this patient. However, in this 
patient, the serine-glycine conversion might also have been enhanced, 
because the glycine formed could, as discussed above, have contributed, in 
part, to an increased porphyrin biosynthesis. The finding that, in these two 
patients, only serine loading resulted in psychotic symptoms supports the 
proposed hypothesis that serine-glycine conversion and the concomitant 
formation of N5,NIO-methylene-FH4 is responsible for the induction of 
psychosis. 
Glycine-serine conversion in patient E.M. also seems to have increased by 
70%, suggesting an increased activity of serine hydroxymethyltransferase and 
the induction of psychotic symptoms after serine loading supports this 
suggestion. However, in the loading experiment with glycine, this patient 
reacted differently from the other patients in that, under these conditions, 
psychotic symptoms also arose. Although this psychosis was accompanied by 
vegetative symptoms, which would favor a diagnosis of porphyria, no 
evidence for an abnormal porphyrin biosynthesis cold be detected. Moreover, 
the two porphyric patients did not show psychotic symptoms after loading 
with glycine, as was the case with patient E.M. and another four patients (see 
Table IV). From the different reactions initiated following the use of glycine 
as a substrate, that forming C02 + NH3 seems to fit the proposed hypothesis 
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the best. As discussed above, the enzyme involved in this reaction is the 
glycine cleavage enzyme by which a one-carbon transfer takes place from 
glycine to PH4 , resulting in the formation of methylene-PH4 . Therefore, it is 
suggested that both enzymes, serine hydroxymethyltransferase and the 
cleavage enzyme, were activated in this patient. The finding that, in this 
patient, glycine excretion was increased during psychosis (see Table I) seems 
to be in agreement with this suggestion. 
Patient A.v.D. also showed psychotic symptoms after glycine loading and 
exhibited an increase in the glycine-serine conversion of about 260%. 
Although no data are available at the moment on glycine formation, the same 
dysfunction as described for patient E.M. might be applicable, since patient 
A.v.D. also reacted with psychotic symptoms after loading with serine as well 
as after loading with glycine. 
In the other two patients who showed a positive reaction to glycine loading 
(I.v.d.T and H.V., see Table IV) and who did not show any symptoms after 
serine loading, an increased activity of the cleavage enzyme might be held 
responsible for the induction of psychotic symptoms. It is noteworthy that 
loading two of the patients with methionine (2 mmole kg- I) did not provoke 
psychotic symptoms in contrast to other reports (Po !lin eta/., 1961; An tun et 
al., 1971). However, in the earlier experiments, patients had to be treated 
with methionine for at least two days before psychotic symptoms arose, while 
in the present experiments, psychotic symptoms arose about 5 h after loading 
with serine and glycine. 
In summary, the results obtained from patients after loading with serine 
and glycine seem to support the proposed hypothesis that an increased 
formation of N5,N1D-methylene-PH4 is responsible for the induction of 
psychotic symptoms. The increased formation of methylene-PH. might be 
due to an enhanced activity of serine hydroxymethyltransferase which may or 
may not be coupled to porphyria. Patients who suffer from this dysfunction 
may become psychotic after serine loading. The psychotic symptoms induced 
after glycine loading, as shown in a second group of patients, might be caused 
by an increased activity of the glycine cleavage enzyme, which also yields 
methylene-PH4. A combination of both dysfunctions seems also possible, 
with a common factor responsible for triggering these reactions. A possible 
candidate might be the enhanced demand for glycine when the biosynthesis of 
ALA is increased. This might not only be the case in patients who suffer from 
porphyria but also in non-porphyric patients during stress or during a 
premenstrual period when plasma levels of corticosteroids and estrogens. 
respectively, are increased. These hormones increase porphyrin biosynthesis 
by increasing the activity of ALA-synthetase, the rate-limiting enzyme of 
porphyrin biosynthesis. Induction of cytochrome P-450, a porphyrin-
containing enzyme involved in drug metabolism, by drugs such as barbitu-
rates or sulfonamides, might also induce psychotic symptoms by increasing 
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porphyrin biosynthesis (see also De Matteis and Rimington, 1962). On the 
basis of these possibilities an explanation may be offered for the beneficial 
effects of a carbohydrate-rich diet or of glucose not only in porphyric but also 
in nonporphyric psychotic patients, namely, by decreasing ALA-synthetase 
activity. 
CONCLUSION 
A group of patients who were suffering from schizoaffective psychosis and 
who showed distinct perceptual disturbances other than hallucinations was 
selected. In contrast to other studies on schizophrenia, the symptoms of these 
patients were shown to be related to transmethylation. In general, the 
therapeutic effect of the prescribed carbohydrate-rich diet was found to be 
superior to treatment with neuroleptics. 
The induction of psychosis by loading patients with serine or glycine seems 
to be in accordance with the proposed hypothesis that an increased formation 
of N5 ,N!O-methylene-FH4 might be a common factor in this group of patients 
related to perceptual disturbances. We are well aware, however, of the fact 
that the evidence presented is indirect. Studies are planned in which we hope 
to obtain more direct evidence for the proposed hypothesis. In addition, 
experiments are in progress which should indicate the specificity of the 
loading test in patients suffering from the described type of schizoaffective 
psychosis. 
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kryptopyrrole = 2,4 dimethyl-
3-ethylpyrrole 
5-hydroxytryptamine 
( seroton i ne) 
harmine 
adrenaline 
HO~ HO~ ~H2 
dopamine 
haemopyrrole lactam 
hydroxy haemopyrrolin-2-one, 
OH-HPL 
~~~/CH3 ~N) N...__CH 
H 3 
dimethyltryptamine ( DMT) 
6-methoxyharmalan 
adrenochrome 
mescaline 
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NASCHRIFT 
Op deze plaats wil lk al dlegenen danken die mlj bij het onderzoek en de 
bewerking van het proefschrift hebben geholpen en bijgestaan. 
Mijn belde promotoren ben ik veel verschuldigd. 
Zander de neurechemische kennis van prof. Bruinvels en zijn vindingrljkheld op 
dit gebied zou de centrale hypothese van dit proefschrift noolt zijn geboren. 
Evenmin zou dit proefschrift tot stand zljn gekomen zonder de "klassieke" - in de 
beste zln van het woord - diagnostlsche kennis van prof. Ladee. Met vrucht heb 
ik vooral van dlt aspect geprofiteerd blj de herkennlng van de in dlt proefschrlft 
beschreven patlenten. 
De leden van het eerste uur van de Werkgroep Biologische Psychlatrie, Willem 
Blom, Ruud van Tuijl en Peter Moleman, ben lk zeer erkentelijk voor hun aandeel 
I 
in het onderzoek en hun adviezen tijdens de bewerking van de verschillende 
hoofdstukken. 
De verpleegstaf van onze afdeling, met name Geert Jurgens en Pierre Reijnders, 
komt alle lof toe voor hun medewerking bij de observaties en het extra werk dat 
het onderzoek met zich mee bracht. 
De beide co-referenten, .prof. Sanders-Woudstra en prof. Wilson, dank ik voor hun 
opmerkingen die tot zinvolle verbeteringen van het manuscript hebben geleid. 
Voor het uitgebalanceerde dietaire werk wil ik hier Ineke Kersten danken; Tiny 
Zaanen en Tineke Jansse verdienen veel lof voor het vele, vele en uiteindelijk 
doorslaggevende typewerk; Hans Baay en Klen Sibbel deden de middelbare 
scholier in mij herleven door hun correcties van de Engelse teksten. 
Ir. P.I.M. Schmitz bespaarde mij veel onnodig werk als gevolg van zijn adviezen 
bij de opzet en uitwerking van het onderzoek. 
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stagejaar Neurologie werd eveneens in voornoemd ziekenhuis doorlopen onder 
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Psychiatrie. 
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